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Abstract
The extraction of disease-gene associations from biomedical publications is a widely inves-
tigated field of research. In previous work, a frequent method was to implement natural
language processing tools that use semantic information to find such associations. How-
ever, most of these approaches are restricted to single documents. Retrieval systems that
predict novel associations across various documents often lack the ability to deal with the
huge amount of resulting candidates. In this work, we present a system that aggregates
information from a large corpora of scientific abstracts. This information is used to build a
comprehensive gene-interaction network, which is then used to predict novel disease-gene
associations. We tackle the problem of candidate reduction by integrating two separate
machine learning methods. We train a support vector machine to classify genes as disease
related or not and a support vector regression model to rank gene-candidates according to
their importance to a specific disease. Thereto, we make use of approved methods and ex-
tend them by a novel investigation of the gene-interaction network. In a model-evaluation
on two gold standards as well as in a case-study in cooperation with biomedical experts,
it is shown that the proposed methods are able to extract disease-gene-associations from
single documents and discover disease-related candidates across multiple documents.
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1 Introduction
1.1 Motivation
The huge amount of biomedical information, which is published daily exceeds the human
abilities to recognize and process relevant knowledge manually. It is barely possible to
extract all available information without any technical support. Due to improved technol-
ogy, nowadays extraction systems can process large corpora of scientific publications for
several applications. One very well investigated research field is the automated discovery
of disease-gene associations.
Finding causal links between biomedical entities e.g. between diseases and genes, receives
a growing attention in the recent years. Fundamental sub-tasks like named entity recog-
nition, entity disambiguation and relation extraction have been tackled very successfully.
Improvements have been made in collecting and providing already extracted information
by storing them standardized in global databases. The exponential growth of research
results provides an essential groundwork for nowadays approaches and with the increasing
importance of machine learning methods, the amount of annotated corpora were enhanced
in quantity and quality. However, the frequent emergence of new challenges, for exam-
ple the BioCreative shared tasks [33, 35, 47], shows the deep and lasting interest of the
biomedical research community.
Due to the growing popularity of Swanson’s fish-oil experiment [64], the task of relation
extraction enlarged. Swanson was able to link researched information across two pub-
lications and discovered new knowledge. In his work, he defined existing information
that can be found in a single publication as private knowledge and information that can
only be gathered by linking private information as (undiscovered) public knowledge. This
encouraged many researchers to develop novel approaches that deal with the discovery
of public knowledge. However, the results of systems that automatically extract public
knowledge, often need further investigations and a subsequent human assessment. Es-
pecially the task of disease associated gene extraction, using public knowledge, should
rather be seen as the generation of disease related gene-candidates. A common way of
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public knowledge discovery is to built interaction networks of the studied concepts. These
networks tend to grow very fast, which also increases their complexity. This results in
a new problem. The number of predicted candidates rises exponentially to the size and
complexity of the network. This makes a human based assessment a lot more expensive
and time consuming.
1.2 Goals And Contributions
In this work, we present a comprehensive system for disease-gene association extraction
as well as disease-related gene-candidate prediction with respect to the human species.
Our approach consists of a modular pipeline, built of several state-of-the-art systems
for entity recognition, disambiguation, and gene-event extraction from a large corpora
of scientific publications. Besides that, we implemented a simple disease normalization
framework (DiNo). We provide a simplified GENIA-event-scheme in order to generalize
event-types. Based on the extracted information, we built a large gene-interaction network
by integrating the transformed gene-events into a graph-database. We use this network
to generate gene-candidates for a specified disease. Since the network was built by an
aggregation of information across various publications, the candidate generation goes
beyond private knowledge and allows us to discover novel disease-gene associations (hidden
public knowledge).
We tackle the problem of candidate reduction by implementing two machine learning
methods. A support vector machine is trained to classify gene-candidates as disease-
related or not, and a support vector regression model is trained to rank genes by their
importance. Both methods can be used to filter gene-candidates by discarding genes that
are either non-related or whose prediction is lower than a threshold. Our feature space
consists of already proved features based on disease-gene co-occurrences and is extended
by novel features based on the interaction network.
We evaluate our models on two different gold-standards. Further, we evaluate our system
by integrating the best performing models and conduct a case-study. We chose Pulmonary
Fibrosis as testing diseases.
Our contribution to the research field is a comprehensive system, that generates a list of
disease related gene-candidates across scientific publications ranked by their importance.
2
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1.3 Outline
After the brief introduction and motivation of our presented work, we give an outline of
the remaining chapters of this thesis.
In Chapter 2, we present related work to our approach. We briefly introduce some
state-of-the-art systems that deal with sub-tasks such as Named Entity Recognition, Entity
Disambiguation, and Gene-Event Extraction. Besides that, we present existing approaches
that tackle the comprehensive task of disease-gene association extraction and systems for
candidate generation.
Chapter 3 gives a brief overview of the existing resources that we used in this work.
This includes two gold-standards, the large corpora of scientific publications, and several
databases for the task of entity disambiguation.
Chapter 4 contains a description of the overall system architecture. We provide a com-
prehensive view to the modular structure. Each module is then described more detailed
with respect to its input and output. We illustrate the functional interaction between the
modules and explain the chain of data processing.
Chapter 5 presents all methods that we use in our approach. This includes integrated
state-of-the-art systems, their functional combination, as well as their combination with
self developed methods. We explain the disease recognition and normalization, the gene-
event extraction, which subsumed the gene recognition, the gene normalization and event
transformation. On top of that, we motivate and describe the data storage and data
supply, which is part of the resource generation and enables the gene-interaction network.
In the last section, we formalize the features, which are used in the machine learning
methods.
In Chapter 6, we describe the conducted experiments and present the evaluation results.
We test various settings against two different gold-standards to determine the best per-
forming models. These models are used in a case-study to test the performance of the
gene-classification task. We present and discuss these evaluation results as well.
Chapter 7 summarizes the results of this thesis with respect to the aim of our con-
tribution. We briefly discuss the evaluation results and give an overview of remaining
problems. The discussion contains some ideas for future work that can help to improve
the system.
3

2 Related Work
We situated our work on Ranking of Disease Gene Associations from large Corpora of
Scientific Publications in the context of entity relation extraction.
Entity relation extraction (ERE) is the task of identifying relations or complex events
between entities, such as diseases, genes or proteins, in natural language texts but also
in existing databases. This includes finding relations between entities of the same type,
e.g. relations between genes, but also across various types. Two frequent types of ERE,
especially in the biomedical research field, are the extraction of gene relations among
each other (GR) and the extraction of disease-associated genes (DAG). Both of them
share common problems like Named Entity Recognition (NER) and disambiguation of
such named-entities (NED). These problems have been addressed relatively successful in
recent years.
Named Entity Relation Facing the challenges of NER, e.g. the unseen word problem or
the mention boundary problem, BANNER [39] turns out to be one of the best performing
approaches. It uses state-of-the-art machine learning techniques to maximize domain
independence. Like other NER approaches [36, 66], BANNER defines the named entity
recognition as a label sequence problem and tackles it by using conditional random fields
(CRF). This combination makes BANNER a powerful framework for extracting disease,
genes and other biomedical entities. In 2008 Dingcheng Li et al. compared CRF with
support vector machines (SVM) for the task of named entity recognition in the biomedical
field. They showed that CRFs outperform SVMs by 22 points in F-score [43] with a total
of 86%.
Named Entity Disambiguation Most of these state-of-the-art approaches extract the
surface form1 of an entity and its position, but do not take the process of NED into
account. However, this is a crucial step, especially if the extracted information need to
be further processed, e.g. in ERE-systems and should be linked to structured information
1The surface form is defined as the unmodified form of how the entity appears in a text.
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in databases or otherwise harmonized with existing knowledge from different sources.
Such normalizations are not restricted to approaches that make use of natural language
processes. In contrast, due to the establishment of many different so called standards for
biomedical named entities, its a common way for both, automatically generated databases
and curated databases to use self defined standards. This leads to a high variation of
surface forms, preferred names and IDs [12,45,67]. Thus, a disambiguation is mandatory
[2, 11,68].
Robert Leaman et al. have introduced DNorm [38], which tackles the problem of disease
name normalization. DNorm makes use of machine learning methods, that learn similari-
ties between mentions and concept names. A common technique in disease normalization
is to make use of databases such as MeSH [44] and OMIM [31] with predefined terms and
concept names for the specific domain [23].
This structure applies also for different types of concepts such as genes. In 2009, Joachim
Wermter et al. challenged the task of gene name normalization and presented GeNo [72].
They illustrated that the task of normalization and disambiguation does not only rely
on machine learning but also on dictionary string matching techniques. The mixture
of both techniques led to an F-score of 86.4 points. However, GeNo uses a build-in
named entity recognition module which is nowadays a common method [38, 71, 72]. It
offers the possibility to influence the NER-output and customize the normalization to
this specific output. Nonetheless, Haw-ren Fang et al. showed that taking NER and
entity normalization separated into account works, too [25].
Jo¨rg Hakenberg et al. challenged a more comprehensive task by not specializing to a
specific taxonomic scope [28]. The task of gene normalization across various species
requires more than a dictionary based string matching and machine learning techniques.
Especially working with inter-species gene names is a complicated challenge. Hakenberg
presented GNAT, a publicly available system for inter-species gene name normalization.
It shows an performance of 81.4 F-score, taking 13 species into account. However, all the
adjustments to deal with the problems of inter species genes, lead to a slightly drop in
the performance for individual species. Overall, they provided an F-score of 85.4% for
human gene normalization.
Relation Extraction Named entity recognition and entity normalization are both ele-
mentary components of relation extraction systems e.g. for gene relations or gene event
extraction and disease-gene association extraction. Finding gene relations in biomedical
literatures is a well established research field. There are various approaches that imple-
ment many different methods. Claudio Giuliano et al. made use of shallow linguistic
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information to extract relations between known entities. They implemented two kernel
functions [58] to identify useful information about local and global structures of a sen-
tence [27].
Katrin Fundel et al. used natural language processing to produce syntactic parse trees.
Using this additional layer of linguistic information, they showed, that they were able to
extract gene-protein relations from a large corpora of scientific abstracts. Fundel men-
tioned the importance of an integrated normalization in order to provide additional in-
formation from various databases [26].
Event Extraction Gene relation extraction is an important challenge for automatic dis-
covery of interactive biomedical entities. Jari Bjo¨rne et al noticed a shift from relation
extraction to the more complex task of event extraction [8]. In contrast to the relation,
an event provides more than just a binary or fuzzy interaction [73] type. An event con-
tains detailed information about the specific interaction like the sentence structure and
the direction of the relation. This could be either positive, neutral or negative. On top
of that, an event could describe a hierarchical structure of multiple relations.
One of the most popular event extraction systems for gene interactions is TEES, [9].
TEES is a highly competitive system that was successfully applied to various BioCreative
shared tasks on event extraction [62]. The system’s pipeline is sub-modular designed.
A pre-processing step contains various state-of-the-art systems for sentence parsing and
named entity recognition. This modular structure makes TEES a powerful framework. It
benefits not only from self made improvements for the actual event recognition task but
also by each local improvement in individual modules.
Gene Interaction Network Sofie Van Landeghem and Jari Bjo¨rne applied TEES to the
entire PubMed and built a protein/gene interaction network [69]. The main goal was to
create a comprehensive network for further research. To reduce the amount of data and
for greater usability they normalized both the extracted proteins/genes and the extracted
events. Landeghem created a network with more than 70 million protein/gene mentions
and 40 million events connecting them for 5.032 species across the full taxonomic scope.
Disease Gene Associations The extraction of disease associated genes (DAG) is a com-
plex task that got increased attention during the recent years. Especially for human dis-
orders, a lot of research was done and a huge amount of knowledge has been aggregated.
Swanson et al. differentiate between private and public knowledge [65]. They defined
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private knowledge as information that can be found within a single publication. In con-
trast, public knowledge is gathered by combining the results from various publications.
In their popular fish-oil experiment [64] they proved this hypothesis. They showed that
two complementary publications could reveal useful information. This knowledge may
not exist in a single publication alone. Their findings motivated several researchers to
face the problem to find undiscovered public knowledge in both biomedical research fields
and beyond that.
Dimitar Hristovski et al. introduced BITOLA, an interactive support system for biomed-
ical discovery of new, hypothetical relations between biomedical concepts [6]. In fact they
use their system to discover disease-gene associations by mining the literature. The main
idea is: if concept A is related to concept B and B is related to concept C than A is
potentially related to C, too. This is a common way to predict new potential candidates
for entity relation [32].
Another method to extract novel DAG candidates was introduced by Jonathan D. Wren
et al. They used text mining techniques to identify biomedical concepts of interest, e.g.
disease and genes and created a network of tentative relationships. These relationships
between concepts are based on co-occurrence. They break down the strict binary co-
occurrence relation into a fuzzy form by taking several indicators into account. The
tentative network is then ranked against a random network model to estimate statistical
significance of the relationships. Wren demonstrated their approach by finding an associ-
ation between CPZ-gene and cardiac hypertrophy. They were able to show that building
a network model has great potential for finding novel candidates.
The approach from Wilkinson et al. is build on a similar base like Wren’s. They build a
network of gene-gene co-occurrences, which were extracted from the literature. However,
their approach differs in both the method and the goal. Wilkinson described the goal as
finding gene-communities that are related to a specific disease e.g. colon cancer. These
gene communities are build by using various graph algorithms to cluster the complex
gene graph. The goal is to provide a list of genes which are either known as related
to a the disease or serve as potentially new candidates. They were able to show that
a network structure is a powerful method to organize related entities with known and
maybe unknown relations.
O¨zgu¨r et al., too, ascertain the benefits of an interaction network to identify disease
associated genes. Their approach builds on a network that contains diseases and genes.
In contrast to the previous presented approaches these interactions do not rely on co-
occurrences but on text mining and dependency parsing. O¨zgu¨r implemented support
vector machines to learn important associations in the network based on graph analysis
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features like betweenness, closeness and centrality. Their goal was to rank genes within
the network to infer unknown DAGs [49]. A similar approach was developed by Changqin
Quan et al. They used a maximum entropy model with topic features and a probabilistic
context free grammar to identify disease gene associations [53].
Besides network-based approaches that are often developed to detect both private and
public knowledge, there are some approaches that restrict their information extraction
to private knowledge. They can be roughly divided into text mining and interaction
database based methods [53]. Hisham Al-Mubaid et al. presented a text mining approach
to find associations between proteins and diseases. Next to extensive NLP and machine
learning methods, a common technique is still the co-occurrence recognition in sentence
or abstract level. This has several reasons. One of them is the fact that negative results
are published with less frequency. Consequently, abstract based co-occurrence leads to a
high recall [17] whereas sentence based co-occurrence rather leads to a high precision [52].
However, Al-Mubaid presents a new technique using information theoretic concepts like
expectations, evidence and Z-score to support the co-occurrence based extraction [2].
M. A. van Driel et al. presented a web-based tool, namely GeneSeeker [68], for the
identification of disease related genes. Their approach uses deep semantic information
about biomedical entities in order to predict a relation or not. The needed information
is gathered from nine different databases. Driel’s web tool is specialized to human genes
and thereby implements some rules for human gene identification, although they gather
the information from databases. This approach requires a gene name disambiguation in
order to map genes and correctly assign collected information.
Comparison In our approach, we tackle the problem of relation extraction between
diseases and genes. We share the common goal to detect already known (private) relations,
but lay the focus on finding undiscovered (public) relations. We define a disease-gene
association as undiscovered, if it is not presented in a curated databases. We aim at genes
that are not in CTD [22], DisGeNET [51] or GTR [54]. In the current system, we restrict
our findings to human genes. However, there is no obstacle on the implementation-side,
that prevents us from taking a larger or different taxonomic scope into account. Our
method contains a pipeline of several state-of-the-art systems [9, 36, 72] and some new
developed frameworks. This pipeline can be divided into several sub-components. At first,
we extract all biomedical concepts of interest, namely diseases, genes and gene events. We
use TEES [9] to extract genes, and gene events from all 22 million abstracts in PubMed.
Both, gene mentions and events are then normalized. For the task of gene normalization,
9
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a modified version of GeNo [72]2 is used. In agreement with biomedical experts, we
implemented an event-normalization tool that fits the GENIA event scheme [34]. The
resulting normalized data is then used to create a gene interaction network similar to
Landeghem in [69]. This network connects normalized genes (nodes) through normalized
events (edges). Besides the gene/event extraction we integrate the CRF tagger developed
by Klinger in [36] for disease name recognition. To normalize the diseaser mentions, we
implemented a simple disease normalization tool, based on DNorm [38].
The actual task of gene candidate generation starts by extracting all abstract based
disease-gene co-occurrences. We call these genes base-genes. For each base-gene that
co-occurs with the specific disease, we create a set of additional-genes by following each
possible path (outgoing from the current base-gene) in the gene network with a specific
path-length. Both, base genes and additional-genes serve as gene candidates. Using in-
teraction networks to detect new, potential genes, leads to a large number of possible
candidates. We tackle the problem by integrating machine learning approaches to
1. classify genes as disease-related or not, using a support vector machine.
2. rank all candidates by their importance to the disease, using a support vector re-
gression model.
In the first case, the result is a set of genes that are likely related to the disease. The latter
case generates a list of genes sorted by their importance. We are able to apply a filter
to eliminate all candidates that are already presented in one of the databases, mentioned
above.
2The full pipeline of GeNo already implements a gene recognition tool was integrated. Since we are
using TEES as recognizer we use only the gene normalization tool of GeNo. A detailed description
can be found in Section 5.2.2
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This chapter gives a brief overview of all materials that we utilized in this work. All
following materials are oﬄine versions that were downloaded at the beginning of the
development in 2014. For convenience, we keep the actual name of each material, but
always refer to the downloaded (and modified) data dump. Most of these materials are
existing databases that are maintained by large biomedical companies like the National
Center of Biotechnology Information [56] (NCBI) or the U.S. National Library of Medicine
(NLM) [1] . This chapter describes six different databases that are widely used in the
literature for similar tasks and accepted by the biomedical research community. These
are
1. the Medical Literature Analysis and Retrieval System Online [1] (MEDLINE),
which is a comprehensive collection of research publications.
2. three different databases that contain biomedical concepts and provide information
for the task of entity disambiguation, namely, Online Mendelian Inheritance in
Men [31] (OMIM), Medical Subject Headings [44] (MeSH) and EntrezGene [45].
3. two curated databases of disease-gene associations. Both are used as gold stan-
dard to train our machine learning methods and evaluate our system. The Ge-
netic Testing Registry [54] (GTR) contains binary disease-gene associations and is
used to solve the classification task. In contrast, we use DisGeNET for the regres-
sion/ranking task, since DisGeNET [51] provides a fuzzy score for each disease-gene
association.
3.1 The Investigated Corpora PubMed
Medical Literature Analysis and Retrieval System Online MEDLINE is a public bib-
liographic database maintained by the U.S. National Library of Medicine. Since the
beginning of the project in 1946, the number of citations grew exponentially to a total
number of 25 million abstracts (2015). MEDLINE covers a large number of biomedical
11
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fields and contains research results from several thousand scientists and physicians. Due
to the enormous size, the huge variety of topics and the free accessibility, MEDLINE
is one of the most important databases for biomedical researchers. The importance is
reflected particularly in the growing number of related projects. This includes many es-
tablished search engines [24,48,59] for purposeful queries, but also the growing number of
biomedical competitions. One of the most popular set of competitions is the BioCreative
shared task [3, 4, 46]. MEDLINE, in its size and complexity, provides an excellent basis
for knowledge discovery and information aggregation.
In this work, we use a downloaded MEDLINE dump from the year 2014. A brief statistic
is shown in Table 3.1. The first column contains the total number of abstracts. The
Total Abstracts ASCII Non-ASCII Considered Abstracts
Count 22.271.876 21.362.350 909.526 21.360.113
Table 3.1: Detailed statistic of the used MEDLINE data dump, downloaded in 2014.
second column contains the number of ASCII-formated abstracts. The reason to split the
abstracts into ASCII and Non-ASCII is that we had issues applying TEES to the Non-
ASCII abstracts, which is an already known problem1. We ignore all abstracts that can
not be processed with our full pipeline in the current system. On top of that, MEDLINE
contains different versions for some abstracts. Although it integrates a versioning index,
each version is listed individually. However, each version of an abstract shares the same
PubMed-ID. We assume that new versions do not change the experimental results or the
semantic content of the abstract but rather correct spelling errors etc.2. Thus, we filter
all abstracts whose PubMed-IDs occur more than once. The actual number of considered
citations is shown in the column Considered Abstracts.
3.2 Data for Entity Disambiguation
Online Mendelian Inheritance in Men OMIM [31] , maintained by the National Center
for Biotechnology Information, is a high quality database for Mendelian disorders, human
genes and gene mutations. Each entry in OMIM is the result of a biomedical experiment
that was curated and evaluated by human scientists. We use OMIM to create a compre-
hensive disease-name dictionary for our disease normalization tool described in Section
5.1.2. The downloaded data dump contains approximately 6.800 distinct diseases.
1https://github.com/jbjorne/TEES/issues/11 Access: 2015-04-25
2http://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html Access: 2015-04-25
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Medical Subject Headings MeSH [44], maintained by the National Library of Medicine,
is a large vocabulary thesaurus of biological terms with the main purpose of indexing
biomedical abstracts and full-text journals. Likewise to OMIM, we use MeSH for disease
normalization. MeSH consists of two different datasets, the descriptor file (Desc) and the
supplemental file (Supp). Desc can be seen as the main resource. It contains thousands of
medical subjects, such as diseases and symptoms, distributed in a large scope of semantic
types. The supplemental file contains additional information to many records of Desc.
However, in the following work we do not distinguish between Desc and Supp but always
refer to the entire MeSH. The downloaded MeSH dump provides up to 16.000 diseases
that we use for the disease normalization task in Section 5.1.2.
EntrezGene EntrezGene [45], maintained by NCBI, is a meta search engine that col-
lects genes from public gene databases. The collected genes are unified and each gene
is provided with a unique ID. EntrezGene provides a lot of information for each specific
gene. Next to others, this includes a taxonomic identifier, a preferred gene-symbol, a list
of synonyms and other nomenclatures. This very extensive storage of gene information
makes EntrezGene a very famous database for gene normalization frameworks. The taxo-
nomic ID makes it even more potent, as it can be used to filter genes that do not belong to
a specific taxonomy, e.g. homo sapiens. EntrezGene distinguishes between several types
of genes: miscRNA, ncRNA, protein-coding, pseudo, rRNA, scRNA, snoRNA, snRNA,
trRNA, other and unkown. In this work, we restrict our interest to protein-coding genes
whose taxonomic-ID is 9606 (homo sapiens). After filtering EntrezGene by applying our
constrains, 20.700 human genes remain.
3.3 Gold Standards
DisGeNET The first gold data that we use is DisGeNET [51]. It is maintained by the
Integrative Biomedical Informatics Group3 (IBI) . DisGeNET is a comprehensive database
that collects disease-gene associations from several public resources. These resources are
public databases that contain disease-gene associations, using different methods of knowl-
edge aggregation. Thus, DisGeNET provides a confidence score for each association. The
score describes a kind of quality of the corresponding association. The more considered
resources contain the specific association the higher the score. Each occurrence in a re-
source is weighted. The weight depends on the underlying method and the scope of the
resource.
3 http://ibi.imim.es/ Access: 2015-04-25
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This gold standard contains a total number of 381.000 disease-gene associations between
16.000 genes and 13.000 diseases. Due to providing a score, DisGeNET can be used to
train regression models that are used to address the task of gene ranking.
Genetic Testing Registry The Genetic Testing Registry [54] (GTR) is a central database
for human researchers to migrate their results from biomedical experiments. The major-
ity of these experiments lays in the interaction between Mendelian disorders and human
genes. With respect to use GTR as gold standard to train machine learning models and
evaluate our system, the composition of GTR has pros and cons. On the one hand, due
to the human curation, it provides a high quality data set. On the other hand, GTR has
a very limited number of entries in comparison to databases whose data is automatically
aggregate. Our data dump of the Genetic Testing Registry consists of 4.200 conditions,
2.800 genes and 5.800 disease-gene associations. Since each presented association is cu-
rated by human knowledge, there is no need for a confidence score qualifying the DAG.
Thus we use GTR as gold-standard data for the disease-gene classification task that is
described in Section 6.1.
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This chapter describes the architecture of our system. It is designed as a pipeline of
consecutive and parallel modules. In the following sections, we describe each module
separately to convey our idea of consecutive data processing. Underlying algorithms are
omitted in this chapter and will be discussed in Chapter 5. To understand the system’s
architecture, it suffices to lay the focus on the analysis of the input and output of each
module. The goal of this chapter is to provide an overview of the entire system, the
data-processing steps and to show which processes can be calculated oﬄine and which
processes need to be calculated online.
Our main motivation to design the system as a pipeline of consecutive and parallel modules
is to provide a comprehensible way of data integration. This should not only effect the
initial data integration but later integrations as well. This design allows us to keep the
system up-to-date by simply integrating newly relevant upcoming data. The modularity
opens up the possibility to update or exchange outdated approaches. One important key
feature during development was a strong transparency of each module. This allows us to
get an understanding of what happens inside the system and makes it easy to discover
weak-points. The overall architecture is illustrated in Figure 4.1.
Information Extraction The illustration shows six separated main modules. It starts
with the Information Extraction module located in the top left corner. In this pre-
processing step, we extract all biomedical entities and information of our interest. In the
current system, this includes gene-events as well as gene and disease mentions. However,
the information extraction is easily expandable. In future work, we may extend the
information extraction to meta-data information for each entity.
Data Conversion In the second main module, namely Data Conversion, we aim at the
preparation of the extracted information to store them persistently in our database. This
step includes the entity disambiguation/normalization, data simplification and finally the
data conversion into the database readable format.
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Figure 4.1: System overview.
Data Storage and Supply The task of persistent data storage by integrating the ex-
tracted information into a database and its fast supply, is shown in the Data Storage
and Supply module. On the one hand, it handles both the initial data integration and
integration of new data. On the other hand, it converts high-level queries into complex
low-level queries. The extracted data is then parsed into high-level objects. It should be
noted that the first three modules are mono-directional connected. Up to this point, all
processes in the modules are calculated oﬄine. However, the bidirectionally connection
between the Data Storage and Supply module and the Gene Ranking System indicates
an online interaction. We simulate this online interaction. In order to speed up the en-
tire process, a lot of frequently queried information was pre-processed earlier and stored
in the Pre-processing Data Storage. The Pre-processing Data Storage can be seen as an
independent background module that stores already queried and processed information
and provides them instantly.
Gene Ranking System Inside the Gene Ranking System module, we distinguish be-
tween the Machine Learning sub-module, that actually processes and calculates the user
queries and the Evaluation module. The latter one is technically not part of the systems
pipeline and is only used during development. However, the user interacts with the Gene
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Ranking System module. He is able to transmit high-level user queries that are internally
converted into high-level system queries. Through the bidirectional interaction with the
database, it gathers all information that is need to accomplish the user query. This could
be either a list of ranked genes for a specified disease or a set of genes that are classified
as disease related.
In the next few sections, each main module is viewed in detail with respect to its input and
output. Therefore, a more detailed illustration of each module is given, which provides
a deeper insight. Most of the modules in turn consist of several sub-modules themselves.
To simplify the descriptions, we use a consistent view to these illustrations. Sub-modules
that are in horizontal order run consecutively. Sub-modules that are vertically stacked
run in parallel.
4.1 Information Extraction
The first module in our pipeline is the Information Extraction. The module consists
of two separated extraction frameworks, namely the Turku Event Extraction System [9]
(TEES) and the CRF based disease tagger [36] (DT). Both frameworks contain NLP
methods that can be applied to plain textual input sources. In this case the input is the
MEDLINE abstract with the PubMed-ID 23848600. We apply TEES and DT in parallel
to the input source. The output of the disease extraction is a file that contains a list
of disease mentions, found in the input text. Each mention is provided with the disease
surface form, the position within the abstract, a sentence identifier in which the disease
was found and the PubMed-ID. The gene/event extraction sub-module generates a file
that contains each gene mention and each extracted event. Similar to the previous file,
each found entity is provided with the surface form, the position within the abstract and
the PubMed-ID. However, TEES does not support a sentence identification. The entire
module with all its sub-modules for the task of information extraction is visualized in
Figure 4.2
4.2 Data Conversion
The second module is the Data Conversion. The objective of this module is to process
the previously extracted information in order to transform it into a database friendly
format. The input of this module are the two previously generated files. First, the disease
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Figure 4.2: Detailed visualization of the Information Extraction module from Figure 4.1
The input is an MEDLINE abstract with the PubMed-ID 23848600. The output are two
independent files that contain the extracted information.
mentions and the gene mentions are normalized. Both normalizations are independent
sub-tasks. Thus, both processes can run in parallel. We use DiNo (described in Section
5.1.2) for the disease normalization and GeNo (described in Section 5.2.2) for the gene
normalization. All normalized genes are then passed to the Filtering module where all
non human-genes are filtered. Both, the normalized diseases and the normalized human
genes are passed to the Entity Linking module. It creates the first information type that
needs to be stored in the database, namely the abstract-based disease-gene co-occurrences
(DGC). In parallel, the Event Simplification module converts complex gene events into
simple gene events. It should be noted that only those gene events are persisted, whose
affected genes are human genes.
Both, simple gene events and DGCs are passed to the RDF Generation. This sub-module
converts its input into the database readable format, namely RDF-triple. The output is a
comprehensive list of triple that were created from both input sources. The entire module
with all its sub-modules is illustrated in Figure 4.3
4.3 Data Storage and Supply
The third module is the Data Storage and Supply. In contrast to the previous two models,
this module contains a bidirectional connection to its next module. The main objective
of Data Storage and Supply is to store previously extracted and converted information
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Figure 4.3: Detailed visualization of the Data Conversion module. The inputs are the
previously generated files that contain the extracted information. The output is a com-
prehensive list of RDF-triples covering the extracted information.
persistently and provide them at query time. In the first step, all created RDF triples are
used as input. The sub-module Integration determines if the triples need to be updated
or not. If the database is empty, it prepares the data for a batch insertion, otherwise
the preparation happens with respect to an updating function. The second input source
comes from the Gene Ranking System in form of a high-level system query (HLSQ). If
the requested HLSQ was already queried, the Extraction module passes the query to the
Storage. The Storage outputs the previously processed high-level database result (HLDR).
If not, the HLSQ is converted into several low-level database queries (LLDQ) that are
needed to gain the requested information. BlaszeGraph processes these LLDQ and passes
the results to the Join Results sub-module. It converts the low-level database results
into HLDR. The result is then persisted in the Storage, which returns it as the modules
output. A detailed illustration of the third module can be seen in Figure 4.4
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Figure 4.4: Detailed visualization of Data Storage and Supply module. It has two differ-
ent input sources and one output. The first input are the RDF triples that were created
during the previous modules. The second input are high-level system queries from the
Gene Ranking System. The output is a high-level database result that answers the given
query.
4.4 Gene Ranking System
The last main module of the entire pipeline is the Gene Ranking System. It is divided
into two larger sub-modules. The first sub-module is the Machine Learning module that
handles the user queries and contains all main methods that are used by the system. The
second sub-module is the Evaluation. It is, technically, not a main part of the system
pipeline but it is used for ML-model training, ML-model evaluation and for the evaluation
of the final system.
The actual main part of the module is the Machine Learning sub-module. A high-level
user query (HLUQ) serves as input. The current system can only process a ranking or
a classification query. Both queries require the same interaction with the Data Storage
and Supply module. They do only differ in the used ML-model which is handled by the
Classification and Ranking-module. Thus, we do not implement a query interpreter but
pass the HLUQ directly to the Feature Extraction module. It converts the user query
into a HLSQ and requests a HLDR from the Data Storage and Supply module. The
result is used in the Classification and Ranking module to create a high-level user result.
Therefore, it uses a previously trained ML-model. The output is a high-level user result
that contains the requested query. This is either a ranked list of genes for a specific
disease (ranking) or a set of disease related genes (classification). The Evaluation sub-
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Figure 4.5: Detailed visualization of the Gene Ranking System module. It has one user
input and one use output (bottom). It shares a bidirectional connection to the Data
Storage and Supply module (left) and creates evaluation results.
module provides two gold standards, such as DisGeNET and Genetic Testing Registry.
Using these gold standards, two different ML-models are trained in the Training module.
Thereto it creates evaluation queries with respect to the positive training examples from
the gold data. The results are used to train the classification model, respectively the
ranking (regression) model. A detailed illustration of the Gene Ranking System module
can be found in Figure 4.5.
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5 Approach and Resource Generation
This chapter presents the methods of this approach and the resources that are generated
during development. The first Section (5.1) is about the disease recognition and the nor-
malization of the extracted disease mentions. We address the task of disease recognition
by using the CRF-tagger that was developed by Klinger et al. in [36]. In Section 5.1.2
we introduce DiNo: a simple disease normalization framework. Section 5.2 describes the
gene-event recognition, followed by the gene normalization and gene filtering. We use
TEES [9] for the task of gene-event extraction which subsumed the task of gene recog-
nition. In Section 5.2.2 we explain the integration of the gene normalization framework
GeNo [72] into the system’s pipeline. Section 5.3 describes the generation of the gene-
interaction network. Thereto, we introduce an event simplification method and we define
a key-term of this thesis, namely Path-Signatures. The section ends with the description
of the construction of these Path Signatures. In Section 5.4, we discuss the persistent
information storage that provides a feature extraction at query time. Those features,
that we use for our machine learning models, are formalized in Section 5.5. The chapter
ends with a brief summary of the presented methods, the generated resources and the
implemented features.
5.1 Disease Recognition and Normalization
This section describes the frameworks that we use to tackle the problem of disease recog-
nition and disease surface form normalization. The first subsection describes briefly the
CRF-tagger by Klinger et al. [36]. In Section 5.1.2 we introduce DiNo, a simple disease-
surface-form normalization framework based on the concept of the state-of-the-art system
DNorm [38].
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5.1.1 Disease Mention Recognition
We address the problem of disease name recognition by using a natural language tagging
framework which is based on conditional random fields. The framework was introduced by
Klinger et al in [36]. The tagging method makes use of two different annotation strategies
for disease recognition. For each strategy a CRF-model was trained separately. Follow-
ing a complex pipeline of natural language processing tools for information extraction
and sentence tagging, these strategies were applied in order to train two conditional ran-
dom field-models. During disease recognition on new sentences, these two models were
combined to get the best results.
The tagger we use in our approach was trained and evaluated on the Arizona Disease
Corpus [40] in cooperation with Matthias Hartung. The evaluation yields a performance
of 80.60% for the F-Score, as shown in Table 5.1.
Setup Precision Recall F-Measure
CRF tagger on
Arizona Disease Corpus
83.09 78.26 80.60
Table 5.1: Evaluation results for the CRF-tagger on the Arizona Disease Corpus.
We applied this model on the MEDLINE-data presented in Section 3.1 and were able to
extract more than 1.5 million instantiations of disease surface forms representing disease
candidates. By investigating the extracted disease surface forms, it turned out that the
data is very redundant and contains way more surface forms than actual disease types.
This leads us to the disease surface form normalization (or abbreviated: disease normal-
ization). We tackle this problem by using DiNo.
5.1.2 Disease Surface Form Normalization using DiNo
Implementing a biomedical normalization tool is usually not a simple task and needs
a thorough investigation of the considered data. For most biomedical entities, there is
already existing literature that describes highly optimized approaches. However, there is
always a gap between existence and usability. An integration of a state-of-the-art system
into a running pipeline often needs a cooperation with the developer and/or is very time
consuming. Due to time issues, our attempt of integrating Robert Leaman’s DNorm [38]-
approach failed. However, we were able to develop and implement DiNo, a simple disease
normalization framework. DiNo follows the example of DNorm which is roughly based on
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TF-IDF. It is optimized to the recognized disease mentions that are produced by the CRF
tagger. In an evaluation of DiNo, we were able to show that this approach outperforms a
previously made attempt as well as our baseline. Hereinafter, both, the implementation
of DiNo and its evaluation are described.
DiNo: A simple Disease Normalization Framework The basic idea of DiNo is to
calculate a set of scores for a disease mention, for each disease within a comprehensive
disease dictionary. The score is a product of the disease name corresponding TF-IDF value
and a string similarity function. The disease, to which the highest score was assigned,
is determined as the normalized disease. The framework can be decomposed into three
sub-components:
1. The generation of a comprehensive disease dictionary.
2. The oﬄine calculation of all TF-IDF values.
3. The online calculation of the set of scores for a disease candidate.
1. Generation of a comprehensive disease dictionary
The first task is the generation of a comprehensive disease dictionary. Each entry in this
dictionary contains a preferred disease name, a list of synonyms and a corresponding ID.
For this purpose, the two databases MeSH and OMIM are used. The composition of both
databases was already described in Section 3.2.
MeSH for disease dictionary MeSH is an ontology based database that supports a
hierarchical structure of many biomedical concepts. Each record has a unique MeSH-ID
which corresponds to each concept in the specific record. This hierarchical structure of a
record is illustrated in Figure 5.1.
The figure shows a simplified hierarchical excerpt of a MeSH descriptor record. Each
record has a list of concepts. To each concept, one or more semantic types are assigned.
In this example, both concepts are settled in the same semantic type, namely Disease
or Syndrome. Besides the semantic type, a concept has a list of terms. Each term is a
synonym describing the main concept (in this case a disease or a syndrome) of this record.
Each dictionary entry has a preferred disease name and a list of synonyms. This preferred
disease name can be found in the preferred term of the preferred concept1.
1It can be found by following the Y -marked edges starting at the Concept List-node.
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Figure 5.1: Simplified hierarchical representation of a record in MeSH. Note, that this
illustration is simplified in the existent information, as well as in the number of concepts
and terms.
In the example excerpt in Figure 5.1, the preferred disease name is Vestibulocochlear Nerve
Diseases. The unique ID can be found in the root-node of the record. It is D000160.
MeSH provides more than 130 different semantical types. However, the records are not
restricted to diseases, but include any medical subject. Thus, there are a lot of semantical
types that we are not interested in. In fact, as described by Chun in [17], only 12 types
may be associated with a disease. We follow the example of Chun and consider all concepts
whose semantic type conforms to one of the 12 types that are shown Table 5.2.
OMIM for disease dictionary OMIM is separated into several files. We use the mor-
bidmap-file which contains all human diseases that are mentioned in OMIM. The struc-
ture of morbidmap is very simple. Each line contains a disease name and a corresponding
OMIM-ID. However, some entries are marked with special characters. In the current
system we ignore all entries that start with one of the following characters: ?, [ or {.
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SemanticTypeName Count
Acquired Abnormality 142
Anatomical Abnormality 143
Cell or Molecular Dysfunction 282
Congenital Abnormality 410
Disease or Syndrome 11.737
Experimental Model of Disease 49
Finding 393
Injury or Poisoning 416
Mental or Behavioral Dysfunction 486
Neoplastic Process 1.179
Pathologic Function 425
Sign or Symptom 720
Total 16.391
Table 5.2: This table contains all semantic types that can be associated with a disease by
Chun. We count the number of occurrences and display them in the right column. Since
a concept can have multiple semantic types, the total number presented here, is actually
higher than the number of considered concepts.
The dictionary The dictionary is built with all entries of MeSH whose semantic type
matches with one of those in Table 5.2, and all non-marked entries in OMIM’s morbidmap.
During the construction of the dictionary, we noticed up to 1.140 overlapping disease
names. An example is the genetic disorder Schwannomatosis. It consists in OMIM with
the ID 162091 as well as in MeSH with the ID C536641. We decided to lay a higher
priority to the MeSH entries and assign the MeSH-ID in such cases. The reason for this
is the hierarchical structure of MeSH and the supply of synonyms.
Before these disease names are written into a comprehensive dictionary, they are pre-
normalized with the following three normalization steps:
1. Each disease name is converted into lowercase.
2. From each disease name, we remove all stopwords (on, in, to, by, at, of, the), punc-
tuations and attachments (this includes modifiers like ’s)
3. Each disease name is tokenized by whitespace-characters, which are used to build a
set of tokens.
The pre-normalization has two important reasons. At first, we reduce the amount of
entries in the dictionary by deleting semantically redundant disease names. The second
reason is to make string matching techniques more accurate.
27
5 Approach and Resource Generation
Table 5.3 shows an example of the Parkinson Disease(D010300) record. The first column
contains the actual concept term as it is mentioned in MeSH. We marked the preferred
disease name of the record with (*). After the normalization, each previous concept-term
is a set of tokens. This is displayed in the mid column in set-notation. The last column
contains the actual dictionary entry. We collapsed equal sets to one single set. These
generated dictionary sets are finally used as synonyms to the preferred set and the corre-
sponding ID. We do the same normalization steps for each OMIM entry and each disease
surface form from the two gold-standards.
Concept Term Normalized Form (Token Set) Dictionary Form
Parkinson Disease (*) {parkinson, disease} {parkinson, disease }(*)
Parkinson’s Disease {parkinson, disease}
Idiopathic Parkinson’s Disease {idiopathic, parkinson, disease}
{idiopathic, parkinson, disease}Parkinson Disease, Idiopathic {parkinson, disease, idiopathic}
Idiopathic Parkinso Disease {idiopathic, parkinson, disease}
Parkinson’s Disease, Idiopathic {parkinson, disease, idiopathic}
Lewy Body Parkinson Disease {lewy, body, parkinson, disease}
{lewy, body, parkinson, disease}Lewy Body Parkinson’s Disease {lewy, body, parkinson, disease}
Parkinson’s Disease, Lewy Body {parkinson, disease, lewy, body}
Primary Parkinsonism {primary, parkinsonism} {primary, parkinsonism}
Table 5.3: Summary table for the normalization of terms for the Parkinson Disease-
record. Each entry points at the same disease ID (D010300 )
The composition, and the total number of diseases that are used to build the dictionary are
shown in Table 5.4. Finally, the dictionary consists of 47.336 unique term-sets, that were
built out of 73.497 disease names. These unique term-sets are mapped to 17.970 diseases.
MesH OMIM Gold Total
Disease Names 67.586 3.431 3.138 73.497
Unique IDs 11.401 3.431 3.138 14.832
Table 5.4: Composition of the disease dictionary that is used in DiNo.
2. Oﬄine calculation of the TF-IDF values
The second step is to calculate the TF-IDF value for each entry in the dictionary. This
requires a definition of the term-variable and the document-variable. For simplicity, we
use in the following description the disease names, but always refer to the corresponding
pre-normalized set in the dictionary. We define a document as a set of all disease names
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and synonyms within the dictionary that points at the same disease-ID. A term is then
defined as a single token within the document. Given a term t and a document d the TF
value is calculated in formula (5.1):
tf(t, d) =
d∑
t′
f(t, t′)
f(t, t′) =

1 if t = t′
0 else
(5.1)
The corresponding term frequency values for the example from Table 5.3 are shown in
Table 5.5.
parkinson disease idiopathic lewy body primary parkinsonism
TF 3 3 1 1 1 1 1
Table 5.5: Term frequency values for all terms in the Parkinson Disease (D010300) -
document of Table 5.3.
The IDF value is calculated with the standard formula: idft = log(
|N |
nt
) where N is the
number of documents D, defined as N = |D| (number of IDs) and nt is the number
of documents that contain the specific term t. We normalize the TF-IDF value with
respect to the sum of lengths of each disease name within the current document. This
normalization has the effect that the sum of all TF-IDF values for a specific disease is
equal to one, regardless of the number of tokens in the disease name. So, we avoid a bias
towards longer disease names.
Consider T (t, d) as a set of all terms in d. The final formula for the TF-IDF value is then
presented in Equation (5.2).
tfidf(t, d,D) =
tf(t, d) · idf(t,D)∑T (t,d)
t′ tf(t
′, d) · idf(t′, D)
(5.2)
All these values can be calculated oﬄine.
3. Online calculation of the scores
The next step is the calculation of the final score for each disease name within the dic-
tionary. This is calculated online as described in the following. The determination of the
score needs two parameters: a disease candidate in pre-normalized surface form C (as we
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did in Table 5.3) and a disease name N from the dictionary. In those representations, the
two names can be compared in order to create a score.
The score is a composition of two values. The first value is calculated by Equation (5.3).
Thereto, we define the similarity function lsd(tCi , t
N
j ). It returns a maximum similarity
score with respect to the Levenshtein distance between tCi ∈ C and a term tNj ∈ N .
levenshtein(x, y) is defined as the character-based distance between the two tokens x and
y as described in [42].
mv(tNj ) = max{lsd(tC0 , tNj ), lsd(tC1 , tNj ), . . . , lsd(tC|C|−1, tNj )}
lsd(tCi , t
N
j ) =

3 if levenshtein(tCi , t
N
j ) = 0
0.9 if levenshtein(tCi , t
N
j ) = 1
max(0, (0.6−
√
tfidftNj )) if levenshtein(t
C
i , t
N
j ) = 2
−0.1 else
(5.3)
We split the string similarity function into four different ranges. If the Levenshtein-
distance is equal to zero, the two terms are equal as well. In this case the function returns
the maximum score of three. We assume that a Levenshtein-distance of one indicates a
spelling error or a spelling variation (e.g. tumour instead of tumor). In this case, the
function returns a similarity score of 0.9. A distance of two may have different meanings.
On the one hand, it could be a spelling error or spelling variation in longer tokens. On
the other hand, it could have a complete different semantic meaning as in tremor and
tumor. An analysis of the considered disease candidates shows that the latter case often
co-appears with a very high TF-IDF score. Therefore, the return value for a distance of
two depends on the TF-IDF score of the dictionary-term. We denote it by tfidftNj . If
the distance is larger than two we assume that the two terms are always semantically
different. In this case we return a small penalty score of -0.1. The final return value is
the maximum of all compared term pairs.
Up to this point, we compared two disease tokens with focus on the dictionary entry. In
the following, another and even stronger penalty function is defined which lays the focus
on the disease candidate. For each term in C that is not in N , a penalty value is returned.
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This penalty is defined with respect to the total number of terms in C. The formula is
illustrated in (5.4):
pen(tCi ) =

− 2.5|C| if max{lsd(tCi , tNj ) : j < |N |} > 0
0 else
(5.4)
With these two functions, the final score can be calculated. This is done by Equation
(5.5).
DiNo-score(C,N) =
|C|−1∑
i
pen(tCi ) +
|N |−1∑
j=0
mv(tNj ) ∗ tfidftNj (5.5)
The entry in the dictionary with the highest score is supposed to be the normalized form
for the disease candidate. The normalized form Dnorm is finally determined by (5.6).
Dnorm(C) = max{DiNo-score(C,N) : N ∈ Dictionary } (5.6)
Real World Example for dysfunction on lipid metabolism In the following, we give a
real world example for the disease mention dysfunction on lipid metabolism. The disease
surface form is compared to two different entries in the dictionary. Thereto, we define
C = {dysfunction, lipid,metabolism}, N1 = {lipid,metabolism, disorders}, and N2 =
{lipid,metabolism, inborn, errors}. Notice that, due to the pre-normalization, C does
not contain the stopword on anymore. Table 5.6 shows the comparison of C and N1.
Table 5.7 compares C with N2.
tCi pen( t
C
i ) Value
dysfunction -2.5 / 3 -0.833
lipid 0 0
metabolism 0 0
(Penalty) Score = -0.833
tNj tfidftNj mv(t
j
N) Value
lipid 0.467 3 1.422
metabolism 0.392 3 1.195
disorders 0.141 -0.1 -0.014
Score = 2.603
Table 5.6: Comparison of the disease mention dysfunction on lipid metabolism and the
dictionary disease lipid metabolism disorders.
The penalty score is calculated on the left of Table 5.6. Since there is only one term in
C that is not in N1, namely dysfunction, and |C| = 3, the penalty is set to −2.5/3. On
the right side of Table 5.6, the positive (maximum) score is calculated. There are two
terms that match exactly to one term in N1 (lipid and metabolism). The TF-IDF values
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for both terms will be multiplied with three. However, disorders cannot be found in C,
so that the mv(disorders) adds a small penalty of −0.014. This penalty has very little
effect, due to the very low TF-IDF value of the frequent term disorders. Table 5.7 shows
the score calculation of N2.
tCi pen( t
C
i ) Value
dysfunction -2.5 / 3 -0.833
lipid 0 0
metabolism 0 0
(Penalty) Score = -0.833
tNj tfidftNj mv(t
j
N) Value
lipid 0.307 3 0.921
metabolism 0.258 3 0.774
inborn 0.311 -0.1 -0.031
errors 0.132 -0.1 -0.013
Score = 1.651
Table 5.7: Comparison of the disease mention dysfunction on lipid metabolism and the
dictionary disease lipid metabolism inborn errors.
Table 5.7 can be interpreted analogously to Table 5.6. However, the positive (maximum)
score is with 1.651 one point lower. This has several reasons. First, N2 is one term longer
that N1. Thus, the TF-IDF values for lipid and metabolism are both lower
2. On top of
that, N2 contains a third strong term, namely inborn, which is not in C.
In Equation (5.7), the values for both dictionary entries are calculated. Equally to this,
the score for each entry in the dictionary is calculated. By considering only these two
entries, the disease mention C would finally be mapped to N1.
DiNo-score(C,N1) = −0833 + 2.603 = 1.77
DiNo-score(C,N2) = −0833 + 1.651 = 0.818
(5.7)
Evaluation of the DiNo Framework We evaluated DiNo on the NCBI disease corpus
and compared it against three different approaches. The first algorithm is a simple nor-
malization approach, which normalizes disease candidates by using the pre-normalization
process that was described in Table 5.3. This approach, hereinafter referred to as SDN,
is our first baseline. The second approach normalizes disease candidates by using the
framework of Paassen [50]. We generated the ontology based database by mapping the
structure of MeSH and extended them by the considered OMIM entries. This approach is
called ODN and serves as our second baseline. On top of that, we compare DiNo against
the state-of-the-art framework DNorm as described in the literature in [38].
2The sum of all TF-IDF values within a dictionary entry is equal to one.
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The settings of the evaluation are equal to those described in Robert Leaman’s evaluation
in [38]. We only compare the generated sets of normalized disease names for a given
abstract. We ignore the exact locations and the total number of diseases. The number
of true positives is thereby defined as the size of the intersection between the gold set
of diseases and our generated set. We use the measures precision, recall and harmonic
F-Score to calculate the micro-average results.
During development, we adjust four parameters to optimize DiNo. This includes all re-
turn values of the lsd-function that were shown in Equation (5.3), as well as the penalty
parameter in Equation (5.4). We found out that the presented values lead to a stable re-
sult. These parameters were set during development and also used in the final evaluation.
The disease mention recognition was done with the previously described CRF tagger from
Section 5.1.1, since DiNo and the two baselines are restricted to normalizations. The per-
formances of all approaches are displayed in Table 5.8. The approach of the first baseline
Setting Precision Recall F-Score
SDN 50.16 26.03 34.28
ODN 41.21 36.21 38.55
DiNo 61.56 61.42 61.49
DNorm (From Literature) 80.30 76.30 78.20
Table 5.8: Micro average results for four different disease normalization approaches on
the NCBI disease corpus test set.
contains a simple cutoff after the first comma and convert it into lowercase. The relative
high precision of 50.16% is probably largely influenced by the high performance of the
CRF tagger (80.60% in F-Score). Although the CRF tagger does not normalize the found
disease names, it is very likely that some of them are already in their preferred form and
matches exactly a disease name in MeSH or OMIM. However, this simple normalization
has obviously a negative effect on the recall which is at 26.03%. A more balancing ap-
proach states the second baseline. It has a lower precision but a higher recall than the
first baseline. However, the F-Score is just slightly higher (38.55%). We were able to
outperform the two defined baselines with DiNo. Both, the precision and the recall are
significantly higher with 61.56% in precision, respectively 61.42% in recall. That leads to
an F-Score of 61.49%. By implementing this relatively simple approach, we outperform
both baselines by approximately 25 points. Unfortunately, we cannot range on the same
level as the highly improved state-of-the-art approach DNorm.
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5.2 Extraction of Gene Interaction Events and Gene
Normalization
In the previous section we described the process of disease recognition and normaliza-
tion. We successfully applied the CRF tagger in combination with DiNo to all MEDLINE
abstracts and were able to extract more than 12 thousand diseases. The next step is to ex-
tract and normalize all genes from MEDLINE. This section is about the gene recognition,
normalization and gene event extraction. The task of gene recognition is subsumed by the
gene event extraction, since we are mainly interested in those genes that are involved in
an event. Further, we only consider protein-coding genes3, we assume semantical equal-
ity between a gene and its protein. Thus, we do not distinguish between a gene and a
protein. We extract gene-events and thereby all involved genes by integrating the state-
of-the-art NLP tool TEES [9]. In a subsequent process, all found gene candidates are
normalized with GeNo [72] and filtered for human genes by comparing the taxonomic ID
with EntrezGene. We evaluate this pipeline against two baselines on the BioCreative-II
gene normalization test set.
5.2.1 Gene Event Recognition
We integrated the natural language processing tool called Turku Event Extraction System,
which is a state-of-the-art framework in the biomedical domain that extracts complex
gene-events on sentence basis. The pipeline of TEES consists of several NLP methods
to convert the plain textual input into a TEES readable format. For this purpose the
GENIA sentence splitter [55] is applied to tokenize the plain text. Each sentence is then
parsed with the Stanford sentence parser [16] to structure them. In the next step, the
NER-system BANNER [39] is used for gene recognition. The output of these consecutive
pre-processings are comprehensively tagged sentences.
The actual event extraction pipeline of TEES starts with a trigger recognition for possible
events. A trigger is defined as a word that probably states a relation between two genes
e.g. induced. The previously generated parse tree of a sentence is then extended by
the trigger annotations. The parsed sentence is used in combination with the annotated
triggers to create a semantical representation of the sentence. In this step, genes and
triggers were linked. Such a linking is called edge. After the detection of all edges, they
are converted into events. An event may consist of several edges. The complexity of a
3We use EntrezGene to identify protein-coding genes.
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single event is thereby defined through the number of edges, respectively the number of
considered genes and triggers.
The data structure of TEES An example of a fully annotated complex sentence is
illustrated in Figure 5.2.
Figure 5.2: The visualization shows a fully parsed and annotated example sentence.
TEES was developed to challenge the GENIA event extraction task [33]. Thereby, the
structure of the extracted information is consistent to the event scheme and the output
format that was especially designed for that task. This scheme is illustrated in Table 5.9.
The left column lists all possible event types that can be triggered. The first six event
types are restricted to a single core argument (a protein). However, the regulation-events
can have either one or two core arguments. These core arguments are placed in the mid
column. They differ in Theme and Cause. As we can see in Figure 5.2 both, Theme and
Cause are semantic labels, describing a relation. The actual core argument is either a
protein or another event type. The right column contains additional information that can
be extracted, if any, to each protein.
Event Type Core arguments Additional arguments
Gene expression Theme(Protein)
Transcription Theme(Protein)
Protein catabolism Theme(Protein)
Localization Theme(Protein)
AtLoc(Entity),
ToLoc(Entity)
Binding Theme(Protein) Site(Entity) +
Phosphorylation Theme(Protein) Site(Entity)
Regulation
Theme(Protein / Event),
Cause(Protein / Event)
Site(Entity),
CSite(Entity)
Positive regulation
Theme(Protein / Event),
Cause(Protein / Event)
Site(Entity),
CSite(Entity)
Negative regulation
Theme(Protein / Event),
Cause(Protein / Event)
Site(Entity),
CSite(Entity)
Table 5.9: GENIA Event Scheme that is used by TEES.
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TEES generates two files that contain the extracted information in a structured format.
A detailed description of the output format can be found on their website4.
TEES was successfully evaluated on the BioNLP 09 Shared Task [8], the BioNLP 11
Shared Task [10] and on the drug-drug interaction challenge [7] as displayed in Table
5.10.
Task F-Measure Rank
BioNLP 09 52.86 1st place
BioNLP 11 51.95 1st place in 4/8 tasks
DDC 11 62.99 4th place
Table 5.10: Evaluation of TEES in several tasks and their ranking.
By integrating TEES, we can extract all gene-events from a given input source and thereby
all genes that are actually involved in an event. However, TEES does not contain a built-
in gene normalization tool. Likewise to the diseases, all genes need to be normalized in
a subsequent process after their recognition. We normalize all gene mentions by using a
state-of-the-art normalization framework called GeNo [72]. This process is described in
the following section.
5.2.2 Gene Surface Form Normalization
In the previous section we described the Turku Event Extraction System that we use in
our approach for gene recognition and gene-event extraction. These gene mentions are in
textual surface form and need to be normalized and disambiguated. This is important to
increases the data density, it enables standardized queries and facilitate the uniqueness
of the systems output. Due to the high variability in gene surface forms, a normalization
is both, an extensive and important task. The variation of the gene surface forms is
mostly given through the high number of synonyms, abbreviations and species depend-
ing spellings. Thus, a gene normalization cannot be done with a single dictionary based
approach, but requires contextual informations. To tackle the problem of gene normal-
ization, we use GeNo [72].
4http://2011.bionlp-st.org/home/file-formats Access: 2015-04-22
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GeNo is a highly performing system for gene name recognition and normalization by
employing multiple statistical and symbolic methods. GeNo’s pipeline can be roughly
organized into four steps. The pipeline starts with the building of a comprehensive
gene dictionary. It includes data from curated gene databases like EntrezGene [45] and
UniProt [18]. The dictionary is augmented by creating variations for each entry. These
variation generator uses approved naming rules and tokenization procedures to convert
a gene surface form to its normalized form. The second step is the gene recognition and
normalization. For this purpose, the machine learning approach Jnet [21] is integrated.
To increase the recall, a dictionary-based method is applied, too. The normalization of
gene candidates is done with the same method that was used for the variant generation for
curated gene names, as described earlier. The last step is the gene mapping component,
which uses a string matching technique to compare each candidate with each entry in
the dictionary. As mentioned in [72], string matching techniques rather lead to a high
recall instead of optimizing the precision. To decrease the number of false positives, a
semantic similarity scorer is applied to each gene candidate. If this similarity score is
below a specified threshold, the candidate is discarded. The result is a list of genes with a
corresponding confidence score. The higher the score, the more likely it is that the given
gene candidate is related to the corresponding dictionary entry.
The text above describes briefly the main procedure of GeNo. However, as mentioned
before, we use TEES for gene recognition. That forces us to modify GeNo’s original
pipeline. In fact, we replace their gene recognition module (Jnet and the dicitonary-based
approach) with TEES. All gene mentions that are found by TEES are converted into a
pre-normalized form like before. After that, the pipeline continues as usual.
Evaluation of the Gene Normalization In the following, the evaluation result of the
modified GeNo pipeline is described, hereinafter referred to as (TEES+GeNo). We use the
pre-trained model GE11 for TEES which was specially trained for the task of gene-event
recognition within plain textual abstracts and was evaluated on the BioCreativ-II event
recognition task. We evaluate (TEES+GeNo) against two baselines on the BioCreative-II
gene normalization test set [46] and compare our results to the original GeNo pipeline
(GeNo) that was described in [72]. Both baselines use TEES in the same way as previously
described for the task of gene recognition.
Similar to the disease normalization evaluation, the first baseline is a very naive approach.
Gene names are case sensitive and often contain special characters like hyphens and
apostrophes. Thus, the first baseline approach simply cuts each gene candidate after the
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first comma. This is motivated through observations that the cut part often contains
additional information or gene-specifications. We name this approach (TEES + SGN).
The second baseline uses the ontology based approach by Paassen [50], that was also
used for the disease normalization. To build the ontology database all human genes
that are mentioned in EntrezGene are considered. Since EntrezGene is not hierarchically
structured, each gene that is labeled with the protein-coding tag represents a single root
node in the database. In order to simulate the hierarchical structure, each synonym5 for
a gene serves as child node. This second baseline is named (TEES + OBGN).
We evaluated all previously mentioned gene normalization approaches on the BioCreative-
II gene normalization task [46]. It challenges researchers to build an approach for gene
recognition and/or gene normalization. The task is specified to human-genes and does
not take other species into account. The test-set consists of 262 PubMed-abstracts with
656 annotated human-genes in total. Each annotated gene includes information about
the surface form, an EntrezGene-ID and a PubMed-ID. The actual position within the
abstract is neither given nor demanded.
The performances of the tested approaches are shown in Table 5.11.
Setting Precision Recall F-Score
TEES + SGN
(first baseline)
13.34 5.87 8.15
TEES + OBGN
(second baseline)
28.37 16.39 20.78
TEES + GeNo 56.33 54.37 55.33
GeNo
(From Literature)
87.8 85.0 86.4
Table 5.11: Evaluation results for several gene normalization approaches on the
BioCreative-II gene normalization test set for human genes.
The first baseline has a very low F-score of 8.15%. The result is composed of a precision
of 13.34% and a recall of 5.87%. The low result suggests a high complexity of the general
task of gene recognition and normalization. The first baseline covers just a simple dictio-
nary lookup without any variant generation or extensive normalization. Thereby the low
5We use the following EntrezGene fields as synonym: Synonyms, Symbol from nomenclature authority,
Full name from nomenclature authority, and Other designations
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precision is probably an effect of the huge gene name variation that can be observed in
the data. The main cause of the low recall is probably the very strict threshold of a pure
lookup with a zero error rate for string matching.
The result of the second baseline shows a slightly better performance. Both, precision and
recall are higher than the first baseline. The result is an F-score of 20.78%. The increasing
performance could be an effect of a general variant generation and normalization that is
used in this approach. However, neither the variant generation nor the generalization is
specifically tailored for gene names. This has a negative effect since common gene names
differ in their structure to other named entities e.g. disease names. This leads us to the
assumption, that a general variant generation and normalization for named entities have
little effect to specific and more complex named entities.
The pipeline of GeNo consists of such a customized variant generation and normalization.
GeNo is strongly specified to the task of gene normalization. This can be recognized in
the evaluation results. Our gene normalization pipeline (TEES + GeNo) outperforms the
two baselines with an F-score of 55.33%. Unfortunately, we were not able to reproduce
the original GeNo score from the literature. This is most likely the effect of merging two
single state-of-the-art systems that are not adapted to each other. In contrast to GeNo,
TEES and thereby the gene recognition, is not optimized to human genes, but finds each
possible candidate regardless of the taxonomic scope. This could have a negative effect on
the precision. The relatively low recall needs further investigations on TEES. A first step
to explain the recall could be an evaluation of TEES for pure gene recognition. However,
this goes beyond the scope of this work and is left for future work. The evaluation results
presented here do not exactly reflect the pipeline that is needed in our approach. To the
best of our knowledge, there is no existing benchmark that exactly captures the event-
recognition only for human genes. Although we outperform the two given baselines, in
future work we will need to work on this issue.
The normalization of biomedical entities is a crucial task of this approach. Since the
gene normalization is at the very beginning of the system, it could cause a lot of damage.
Wrongly normalized entity names influence the entire system and could lead to bad eval-
uation results and, with respect to the discovery of public knowledge, to the generation of
wrong assumptions. Especially for the task of hidden knowledge discovery and predicting
new gene candidates, it is mandatory to make the process of normalization re-traceable.
This helps researchers and annotators to understand the systems output more effectively.
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5.3 Gene-Interaction Network
In this section, we describe the generation process of a comprehensive gene-interaction
network. Thereto, we discuss the gene-event normalization/simplification and the process
of event graph transformation. An event has been defined as a set of coherent event
types, genes and additional arguments. In most cases, an event consists of more than
one event-type. Such complex events need to be simplified in a graph transformation
process. The objective of the transformation is to convert a given arbitrarily complex
event into simpler sub-events. We do this in order to reduce the complexity of the data
and make them persistently storable into our database. As mentioned before, TEES
generates plain textual output following the file description of the event extraction task.
These files contain structured information about the graph structure for each gene-event
that was extracted. The first step that needs to be done, is to convert this textual
output into a graph structure. Since our entire system was written in the programming
language java [5], we map the input into a java tree object. After that, the internal
tree representation is transformed into simpler sub-events. Therefore, we extract several
subtrees. Each sub-tree is restricted to a maximum number of two leaf-nodes, respectively
two genes, describing a simplified event between both. We call the converting from text
into a tree Graph Construction and the latter step Graph Transformation.
5.3.1 Graph Construction and Transformation
In order to make the graph transformation process more comprehensible, we illustrate
it based on the example sentence shown below. This example sentence is an excerpt of
the publication: “Upregulation of heat shock protein 27 confers resistance to actinomycin
D-induced apoptosis in cancer cells.” with the PubMed-ID 23848600.
(5.8) HSP27 knockdown leads to an increase in Act D-induced caspase 3 and
caspase 7 cleavage, and sensitizes rhabdosarcoma cells and breast cancer cells to
Act D-induced apoptosis[...].
Graph Construction In Section 5.2.1, two files were mentioned that are generated by
TEES. Usually, these files contain several hundred lines each. The complexity depends
on the number of events, proteins and additional information that was found in the input
text. In a merging process, all event depending lines from both files are extracted. An
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example of such extracted information from the sentence in Example 5.8 is shown in
Listing 5.1.
The generated file can be roughly divided into three different types of lines. Line 1, 2 and
3 belong to a protein/gene6. In this example, there are three different proteins HSP27,
Act D and caspase 3. The next three lines are specifications for a (sub)-event and contain
meta information. The last three lines represents the actual events. Line 7 shows an event
that is bounded to a single protein. The Negative regulation (E195) is bounded to HSP27
over a Theme-identifier. There is no specification of how this regulation needs to be initi-
ated. Line 8 shows a very frequent event type. This Positive regulation (E196) connects
two genes, precisely Act D as cause-gene and caspase 3 as theme-gene. Usually, this is
already a valid event on its own. However, it exists a more complex event that subsumed
E196. This complex event is shown in the last line. It shows a complex event between
two events. The cause-event E195 causes a positive regulation to the theme-event E196.
Considering this example, we have in fact two valid events: E196 and E198. Since E196
is subsumed by E198, we keep that in mind but lay the focus in the following to the more
complex event.
1 T371 23848600 758 763 Prote in HSP27
2 T372 23848600 798 803 Prote in Act D
3 T373 23848600 812 821 Prote in caspase 3
4 T706 23848600 764 773 N e g a t i v e r e g u l a t i o n knockdown
5 T707 23848600 804 811 P o s i t i v e r e g u l a t i o n induced
6 T708 23848600 786 794 P o s i t i v e r e g u l a t i o n i n c r e a s e
7 E195 N e g a t i v e r e g u l a t i o n : T706 Theme : T371
8 E196 P o s i t i v e r e g u l a t i o n : T707 Cause : T372 Theme : T373
9 E198 P o s i t i v e r e g u l a t i o n : T708 Cause : E195 Theme : E196
Listing 5.1: Merged information of the sentence in Example 5.8.
Up to this point, we have an understanding of the textual representation of a complex
event. The next step is to convert these lines into a graph. To address this problem,
we implemented a simple tree object in java, covering all necessary functions to store
all needed information. Figure 5.3 shows the graph representation of the complex event
E198.
6As mentioned before, we do not differentiate between genes and proteins.
41
5 Approach and Resource Generation
After converting the textual representation into a graph, the complex event can be trans-
formed into sub-events. By that, we assume that there is a possibility of dividing the
event-tree into sub-trees, without any or at least, with an acceptable loss of semantic
information. Besides minimizing the loss of information, it is also important to avoid the
generation of new and possibly wrong information. Tackling these requirements we de-
veloped an algorithm, in agreement with a biomedical expert, that takes both conditions
into account.
Figure 5.3: Graph representation of the complex event E198 that was shown in Listing
5.1.
Graph Transformation The algorithm is composed of two components that are called
subsequently for each complex event-tree. The objective of the graph transformation is
to convert complex events into simpler sub-events that can be stored in our database.
Thereby, we create a comprehensive gene-interaction network.
1. Determination of the cause-gene and the theme-genes
We define a cause-gene as a gene, which manipulated at least one other gene. Such a
manipulating role is defined by the semantic keyword Cause. Besides that, we define a
theme-gene as a gene that is manipulated by at least one cause-gene. We assume, that a
theme-gene within a cause-event of a complex event, has a manipulating role to each gene
in the sub-tree theme of the complex event. Taking the example from Figure 5.3, there
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are two valid cause-genes, namely HSP27 and Act D. If the cause is HSP27, then the set
of themes contains Act D and caspase 3. If Act D is chosen as cause, then caspase 3 is the
only theme. An other example is illustrated in Figure 5.4. In this example event, gene1
serves as cause for gene2 and gene3. gene2 serves as cause of gene3. However, gene3
is not a valid cause-gene.After the determination of causes and themes, a list of tuples
can be created. Each tuple consists of exactly one cause-gene and one corresponding
theme-gene.
Figure 5.4: Complex event with a valid cause event. Each gene in the cause event serves
as cause for the gene in the theme-event. All possible cause-genes are outlined boldly.
2. Generate sub-trees for each tuple
In the second step, we use a simple form of the Dijkstra algorithm [60] to extract the path
between the cause and the theme within a tuple. The Dijkstra algorithm always finds
the shortest path between two nodes in a given graph. Since each event is represented in
a tree rather than a graph, there is just one solution. By using this algorithm, a set of
sub-trees is generated, representing each sub-event of a complex event. Each tree within
the generated set consists of exactly two leaf-nodes (the cause-gene and the theme-gene)
and at least one event-type-node. In addition, two nodes are connected trough exactly
one directed edge, outgoing from the cause-gene. Three subtrees can be extracted from
the example in Figure 5.3. These are illustrated in Figure 5.5 and 5.6.
At the beginning of this section, we considered the complex event and mentioned a second
valid event (E196). By applying the graph transformation to the complex event, every
possible valid event is taken into account. However, a last step is required to convert
the event trees into the database readable format. In this step, all non-leaf nodes and
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edges are collapsed into a single edge. This new edge contains each information that was
previously represented from all edges and nodes between the two leaf-nodes. Due to the
structure of a sub-tree, this conversion can be done without any loss of information. The
result can be written as triple, that consists of two genes and their complex relation.
Figure 5.5: This figure contains two extracted subtrees for the example tree in Figure
5.3. Both of them have HSP27 as cause. The left figure shows the path to Act D, the
right figure to caspase 3. The edges are adjusted to be outgoing from the cause-gene,
marked as dashed lines. However, the edge descriptions do not changed.
Figure 5.6: This figure contains the third extracted sub-tree between Act D (cause) and
caspase 3 (theme). The edges are adjusted to be outgoing from the cause-gene, marked
with dashed lines. However, the edge descriptions do not changed.
For the three extracted sub-trees in Figure 5.5 and 5.6, we finally generate three following
new trees as shown in Figure 5.7. With these triple-like trees, a comprehensive gene-
interaction network can be built, using the graph storage ability of our database. The
actual storage is described in Section 5.4.
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Figure 5.7: This figure contains all three final trees that are generated by the graph
transformation from the tree in Figure 5.3.
5.3.2 Extraction of Path Signatures
In the previous section, the process of generating the data for a comprehensive gene-
interaction network was described. The result was a set of apparently independent triples,
that can be stored in the database. However, the database generates a comprehensive
network considering all genes and their transformed events. The integration into the
database is described in Section 5.4. The interaction network enables the connection of
genes beyond their abstract based relation and find new undiscovered public relations
[65] between genes. Therefore, we define a new term. We call consecutive relations
between two genes in the interaction graph Path Signature, referred to as signature. These
signatures are later used to formalize some features.
In the following, we describe the extraction of such signatures. On top of that, we intro-
duce a signature simplification/normalization process in order to limit the variance.
Since the network contains directed edges, a distinction between incoming and outgoing
signatures is needed. Thus, a signature can be either starting from a cause-gene gcause
and ending at a theme-gene gtheme or vice versa. Thereby it may have to pass some nodes.
These passing nodes are called bridge-genes. A signature is defined as outgoing if each
edge between gcause and gtheme is outgoing from the current node. An incoming signature
can be defined analogously. Due to the cyclic structure of the network and the huge
amount of data it is also crucial to limit a signature in its length by setting the maximum
number of bridge-genes. The generation of a signature from the gene-interaction network
is composed of three steps. All three steps are explained with respect to an outgoing
signature. Incoming signatures can be generated analogously. The generation of gcause
related signatures starts by the extraction of all gcause related raw-signatures.
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1) Extraction of Raw-Signatures from Database The first step is to find all paths
with a specific length between gcause and gtheme in the network. This is handled by the
database (see Section 5.4) with the following query:
1 PREFIX e: event
2 SELECT ?OutRel1 , ?OutRel2 WHERE
3 {
4 <e:HSP27 > ?OutRel1 ?BridgeGene1 .
5 ?BridgeGene1 ?OutRel2 <e:caspase+3> .
6 }
Listing 5.2: SPARQL query to retrieve a list of outgoing paths between HSP27 and
caspase3. Each path consists of two outgoing relations in consecutive order.
A maximum number of one bridge-gene leads to a number of two relations between these
genes. A maximum number of two bridge-genes leads to three relations etc. Figure 5.8
illustrates an example gene-interaction network. It shows two possible outgoing paths
starting at HSP27 and ending at caspase 3 and passing one bridge-gene. These paths are
highlighted as thick lines. The dashed lines are examples of incoming relations, starting
at HSP27 and ending at caspase 3. In this example, an incoming path exists only over
two bridge-genes. For convenience, all relations are abbreviated with Rel followed by a
unique ID e.g. Rel3. These relations can be very complex as mentioned in Section 5.3.
Figure 5.8: Illustration of a gene-interaction network of eight different genes. The re-
lations between HSP27 and caspase 3 are emphasized. The thick lines show outgoing
relations, starting at HSP27 and ending at caspase 3. The dashed lines illustrate incom-
ing relations starting at HSP27 ending at caspase 3.
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The result of this component is a set of lists of relations between gcause and gtheme, sorted
in consecutive order. Each list contains exactly n relations where n is the number of
bridge-genes+1. From the example graph in Figure 5.8, two outgoing relation-lists for
HSP27 can be extracted:
(5.9) (Rel1, Rel2)
(5.10) (Rel3, Rel4)
Due to lack of space, we create the following abbrevi-
ation table that is used in the following step.
We create the corresponding raw-signatures by build-
ing a comprehensive path, representing all relations
in the list. We do this by merging them, separated by
colons, in consecutive order as shown in Listing 5.8
Full Term Abbreviation
CAUSE CS
THEME TH
Positive relation Pos rel
Negative regulation Neg rel
Localization Loc
Figure 5.9: Abbreviation table for
event types.
1 TH: Neg reg :CS : Pos reg :TH: Pos reg :TH:CS : Pos reg :TH
2 CS: Pos reg :TH:CS : Neg reg :TH:CS : Pos reg :TH: Loc :TH
Listing 5.3: Two raw-signatures that were extracted from the example interaction
network in 5.8.
2) Signature Normalization In order to reduce the variability and make signatures more
generalizable, each relation is normalized in a subsequent process. The complexity of a
raw-signature is determined by the event-scheme in Table 5.9 and the number of bridge-
genes. Since we want to use the final Path Signature as features, their variability needs
to be reduced. This is done by a normalization / generalization of the raw-signatures. A
generalization always includes a loss of information. To minimize this loss, we have made
two assumptions in collaboration with biologists.
1. Abstraction from Semantic Path Information
The first assumption is, that the current notation contains some terms with very low
information content. These are all terms that are actually not an event, in this example
CAUSE and THEME. Both of them can be seen as semantic values that carry information
of the original event. If the Path Signature would remain in this notation, there would
be a lot of variations that may express the same or almost the same information with a
usage of slightly different terms. An example can be seen in Figure 5.7. The first two
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relations differ only in the last term (THEME/CAUSE). Assuming that these terms carry
only tree depending information, a crucial step is to remove all terms that do not belong
to an actual event. The modified forms so far, are listed in Listing 5.3.
1 Negat ive Regu lat ion : Po s i t i v e Regu l a t i on : Po s i t i v e Regu l a t i on : Po s i t i v e Regu l a t i on
2 Pos i t i v e Regu l a t i on : Negat ive Regu lat ion : Po s i t i v e Regu l a t i on : Lo c a l i z a t i on
Listing 5.4: Simplified form of the raw-signature in Listing 5.3. All non-event type terms
are removed. In this case it is only the THEME and the CAUSE keyword.
2. Generalizing of Event Types
On top of this reduction, we assume that similar event types can be generalized with-
out losing too much information. A modified GENIA event-scheme that we use in our
approach, is displayed in Table 5.12. It displays all reductions and generalizations. The
generalization comprises the encapsulation of Gene expression and Transcription into
Expression and all forms of regulations to Regulation.
Generalized
Event Types
Event Type Core arguments Additional arguments
Gene expression Theme(Protein)
Expression
Transcription Theme(Protein)
Catabolism Protein catabolism Theme(Protein)
Localization Localization Theme(Protein)
AtLoc(Entity),
ToLoc(Entity)
Binding Binding Theme(Protein) + Site(Entity) +
Phosphorylation Theme(Protein) Site(Entity)
Regulation
Theme(Protein / Event),
Cause(Protein / Event)
Site(Entity),
CSite(Entity)
Positive regulation
Theme(Protein / Event),
Cause(Protein / Event)
Site(Entity),
CSite(Entity)
Regulation
Negative regulation
Theme(Protein / Event),
Cause(Protein / Event)
Site(Entity),
CSite(Entity)
Table 5.12: Reduced GENIA event scheme.
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The simplification comprises the deletion of all additional arguments and tree depending
identifiers like Theme and Cause. The additional generalization transforms the signatures
into the following form:
1 Regulat ion : Regulat ion : Regulat ion : Regulat ion
2 Regulat ion : Regulat ion : Regulat ion : L o c a l i z a t i o n
Listing 5.5: Simplified and generalized form of the raw-signature from the example in
Listing 5.3.
Signature String Compression The third and last step of the signature generation is
a compression of the current form. On top of these simplifications and generalizations,
which are based on assumptions, we use one last compression strategy to shorten the
string length of very complex signatures. This strategy does not change the content of
information, but is just a different spelling and leads to a condensation of information.
We collapse consecutive equal relation-types and assign them a new term. These terms
are composed of the prefix Multiple, the actual generalized event-type e.g. Regulation and
an identifier that counts the number of collapsed events e.g. 2. Listing 5.6 shows the
final forms of the modified signatures from Listing 5.3.
1 Mult ip l eRegu la t i on 4
2 Mult ip l eRegu la t i on 3 : M u l t i p l e L o c a l i z a t i o n 1
Listing 5.6: Final form of the two Path Signatures from the example in Listing 5.3.
After this compression, the generation of a Path Signature is complete. In this form they
will be used to define the features in Section 5.5.2.
5.4 The Graph Database
In the last two sections, the data extraction and preparation has been described. That
includes the entity recognition, the entity normalization, the data filtering, and the data
generation to build a comprehensive gene-interaction network. The extracted data need
to be saved persistently in order to guarantee an access at query time. In this section, we
describe the population of the databases. Thereto, the choice of the database is motivated
in the following subsection. After that, the required data structure is explained and we
describe the conversion of the previously prepared data into this format.
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5.4.1 Blazegraph
This section describes and motivates briefly the choice of the database that was used
to store the extracted information persistently. The choice of a (Resource Description
Framework [13]) RDF-graph database is based on the fact that both, gene-disease and
gene-gene relations can be represented as a triple. The database needs to connect all
genes through their relations, not only with direct relations, but among longer paths.
Therefore, the database needs to support graph mining techniques. To address all these
requirements, we decided to use bigdata (also known as Blazegraph since 2015), which is
maintained by Systap 7. Blazegraph is a freely available database framework. It is highly
scalable up to 50 billion entries on a single machine, which makes it easily usable, even
with limited resources. Blazegraph stores each entry as resource description RDF-triple
but supports also named graph quadruples. Named graphs offer also the possibility to
add additional context knowledge in future work without changing to much of the data
structure. The data can be accessed by using powerful low level API’s like Sesame [14].
Sesame supports several query languages. This includes SPARQL, which was accepted as
a standard by the World Wide Web Consortium (W3C). Thus, a lot of well documented
examples exist that simplify the development of our system.
5.4.2 Population of the Database
To store the extracted information, the data needs to be converted into RDF-triples/
RDF-quadruples. This process is described in this section. An RDF triple contains
three fields, namely Subject, Predicate and Object. A named graph quadruple contains an
additional field, the Context. Such a triple describes a relation between the Subject and
the Object. The Predicate covers their relation. Each field can store different data types
and usually has a semantic meaning and provides predefined values. However, there is no
restriction to use the fields in a different way.
In our case, we need to store three different types of triple.
1. The first type of triple stores an abstract based co-occurrence of a disease and a
gene. We call this type of triple co-occurrence triple (COT).
2. The second type of triple stores the event-based relation between two genes. We
name it gene-event triple (GET).
7http://www.blazegraph.com/ Access: 23.04.15
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3. The last type of triple is similar to the first type. It stores a relation between a
disease and a gene. However, this relation is not based on co-occurrences, but is
determined through the gold data. We name them gold-data triple (GDT).
Construction of the Co-occurrence Triples Each COT contains a disease, a gene and
the PubMed-ID in which both entities were extracted. Given a set of diseases D and a
set of genes G, which are extracted from the same abstract A, we built a set of triples
{d,A, g|d ∈ D, g ∈ G} to determine all COTs for A. Thus, the total number of COTs of A
can be calculated as |D| · |G|. This abstract based co-occurrence is thereby a very broad
definition. However, as motivated in the related work chapter, most of the published
findings describe successful experiments. Thus, we assume that the majority of abstract
based co-occurrences share a positive correlation. By taking all co-occurrences into ac-
count, we avoid the missing of possible relations and increase thereby the systems recall.
On the other hand, we create a lot of false positives that need to be eliminated. Table
5.13 contains an excerpt of all co-occurrences that were found in the example sentence in
Example 5.8.
Disease (Subject) AbstractID (Predicate) Gene (Object) ContextID (Context)
breast cancer 23848600 Act D C125577
breast cancer 23848600 caspase 3 C125578
breast cancer 23848600 caspase 7 C125579
breast cancer 23848600 HSP27 C125580
sarcomas 23848600 Act D C125581
sarcomas 23848600 caspase 3 C125582
...
...
...
...
sensitizes rhabdosarcoma 23848600 HSP27 C125588
Table 5.13: Excerpt from all COTs that can be extracted from the given sentence in
Example 5.8.
We built a COT as follows: The disease is put into the Subject field. The Predicate field
is filled with the abstract ID, since its meaning comes closest to a relation. Thereby, the
Object contains the related gene. In the last field we store an entry corresponding context
ID. This ID serves as pointer to the current entry. In future work we will be able to use
this ID as a reference to store additional information to the corresponding COT. This
could be for example the onset/offset of the involved entities or information about their
surface forms to make the normalization process re-traceable.
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Construction of the Gene Event Triples Each GET consists of a cause-gene, a theme-
gene and their event-based relation. The main process of event generation was already
described in Section 5.2. The generated triples for each extracted sub-tree as illustrated
in Figure 5.5 and 5.6, are shown in Table 5.14.
Cause
(Subject)
Complex Relation
(Predicate)
Theme
(Object)
ContextID
(Context)
HSP27 THEME:Neg reg:CAUSE:Pos reg:THEME:Pos reg:CAUSE Act D E5311
HSP27 THEME:Neg reg:CAUSE:Pos regTHEME:Pos reg:THEME caspase 3 E5315
Act D CAUSE:Pos reg:THEME caspase 3 E5316
Table 5.14: This table shows all generated triples that could be generated from the sen-
tence in Example 5.8. Due to lack of space we shortened the event type names. Thereto,
Neg rel stands for Negative regulation, Pos rel can be analogously interpreted.
The amount of gene relations in this example is substantially lower in comparison to
the number of co-occurrence triples. There are only three different GETs. The data
allocation to the individual fields is similar to the co-occurrence triple. The cause-gene
is assigned to the Subject field. The relation is stored as Predicate. The theme-gene
serves as Object. The corresponding context ID is stored in the Context field and can be
interpreted analogously to the co-occurrence context ID.
Construction of the Gold Data Triple The third type of triple covers an entry in the
gold data that were previously described in Section 3.3. The structure and meaning of a
gold triple is very similar to a co-occurrence triple. It contains exactly one disease and
one gene. They only differ in the predicate. A COT stores the abstract ID in which both
entities were found and the GDT contains the information from which particular gold
data this association was extracted. In the current system, this could be either ncbigtr or
disgenet. Table 5.15 shows six example GDTs.
Technically, all three types of named triples can be stored in a single comprehensive
database. However, we decided not to do so, but to store the event type triples in its own
database. The co-occurrence triples were put together with the gold triples. This split has
benefits and drawbacks. During the design of the feature vector, a clear distinction into
features that are based on COTs /GDTs and features that are based on GETs emerged.
Thus, a split into two databases seems legit. It will ease the way of querying data and
speed up the process. A clear negative aspect is the higher complexity of querying any
kind of interaction between COTS and GETs. This requires both, more time and resources
since pre-queried data need to be stored temporarily in the memory.
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Disease (Subject) Gold Data (Predicate) Gene (Object) ContextID (Context)
hyperlysinemia ncbigtr AASS GTR13
malignant hyperthermia ncbigtr RYR1 GTR4605
townes syndrome ncbigtr SALL1 GTR4616
malignant hyperthermia disgenet RYR1 Dis52
pulmonary fibrosis disgenet SFTPA2 Dis2141
endometriosis disgenet MMP3 Dis42577
Table 5.15: Six example triples that describe gold entries from the GTR respectively
from the DisGeNET gold data.
Another problem could appear in the future. A visualization of the entire data is not
simple. Usually there are a lot of visualization tools for RDF-data like vizualRDF 8,
RDF-Gravity9 or IsaViz 10. However, a split into two databases makes a comprehensive
visualization more complicated.
Finally, the positive aspects predominate and we decided to populate two separate databases.
Thus, all COTs and GETs are stored in the disease-genes-association-database, here-
inafter referred to as DGA-DB. All event triples are stored in the gene-interaction-
network -database, referred to as GIN-DB.
Insertion of the triples In the following we give an example query to store a co-
occurrence quadruple.
1 PREFIX c: cooccurrence
2
3 INSERT DATA
4 {
5 GRAPH <c:C0> { <c:breast+cancer > <c:23848600 > <c:Act+D> }
6 }
Listing 5.7: Concrete co-occurrence quadruple insertion into the DGA-DB for the disease
breast cancer and the gene Act D in SPARQL-notation.
8https://github.com/alangrafu/visualRDF Access: 2015-04-15
9http://semweb.salzburgresearch.at/apps/rdf-gravity Access: 2015-04-15
10http://www.w3.org/2001/11/IsaViz Access: 2015-04-15
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The Resource Description Framework was technically invented to describe semantic web
data. Usually, such data is provided with a namespace that declares the scope in which
the attribute value is defined. In the current system, we do not make use of the benefits
that can be gained by choosing accurate namespaces. Nonetheless, the data is stored in
URI-notation and a namespace declaration is mandatory. The example in 5.7 shows an
insertion for a co-occurrence triple into the DGA-DB. The triple for the gold-data and
the gene-events can be inserted analogously. They differ only in the namespace gold for
gold-data triples and event for gene-event triples.
5.5 Feature Extraction
In the last sections, the data generation and the persistent storage of the extracted infor-
mation was described. The data could be separated into three different kinds of named
RDF-triple. We populate a separate database for the gene-gene associations and a sep-
arate for the disease-gene associations. This was motivated by the investigation of the
formalized features. As we will see in this section, the triple separation improves the
simplicity of querying the data. We formalize all features and describe the methods to
extract them from the two databases. Based on these features, we build a comprehensive
feature vector that represents a data point to train machine learning models. Finally, the
main goal of this work, the gene classification and the gene ranking can be tackled.
Seven feature groups are defined in total. Each feature group adds a number of features
to the comprehensive feature vector that is used as training data for the machine learning
methods. This arrangement in groups can again be divided into two types.
The first type is based on disease-gene pairs. These features are based on the co-occurrence
between diseases and genes. We call these feature groups co-occurrence based features.
They include the following five feature groups:
1. Entropy - The Entropy feature group contains the entropy of the gene and the
entropy of the disease.
2. Co-occurrence -It contains three features that describe the probability of the disease-
gene pair with respect to three different types of normalizations.
3. Grade -The grade describes the normalized occurrence of a gene or a disease in the
database.
4. Odds Ratio -The odds ratio describes the statistical dependency between a gene and
a disease within the dataset.
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5. TF-IDF - This feature contains the TF-IDF value for a disease-gene pair. A Term
is defined by a gene that co-occurs with a disease (the document).
The second type of feature groups is called gene network features. These features are
disease independent and based only on the gene-interaction network. This type contains
the following feature groups:
1. Path Signatures - A signature describes a path between a given cause-gene and a
theme-gene in the gene-interaction network as defined in Section 5.3.2. We consider
each outgoing signature with a specific length as single feature. The actual value is
defined by the TF-IDF value of a signature within the corresponding gene.
2. Gene Connectivity - These features contain information about the connectivity of
the gene in the network with respect to the number of outgoing and incoming
signatures.
5.5.1 Co-occurrences Based Features
In the following subsection we describe all features that are based on co-occurrences
between diseases and genes.
Before formalizing these features, some variables need to be predefined. We denote Tdiseases
as the set of all triples within DGA-DB. Further we define D as the set of all existing
diseases and G as the set of all existing genes in DGA-DB.
On top of that we define three subsets of Tdiseases:
1. Td = Subset of triples with a fix disease d and all co-occurring genes.
2. Tg = Subset of triples with a fix gene g and all co-occurring diseases.
3. Tdg = Subset of triples with a fix disease d and a fix gene g.
where Tdg ⊆ Td, Tdg ⊆ Tg and Tdg = Td ∩ Tg as illustrated in Figure 5.10.
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Figure 5.10: Illustration of the three defined subsets: Td,Tg and Tdg of Tdiseases for the
example disease breast cancer and the gene HSP27.
To calculate these subsets, we used three SPARQL queries that are shown in Listing
5.10,5.9 and 5.10. The first query extracts all co-occurring genes for the example disease
breast cancer and is denoted as Td=breastcancer:
1 PREFIX c: cooccurrence
2 PREFIX g: gold
3
4 SELECT DISTINCT ?Rel , ?Gene WHERE
5 {
6 <c:breast+cancer > ?Rel ?Gene .
7 FILTER(?Rel != <g:disgenet > && ?Rel != <g:ncbigtr > )
8 }
Listing 5.8: SPARQL query to retrieve a list of co-occurring genes for the specific disease
breast cancer in URL notation. The result is filtered to receive entries that do not belong
to any gold standard.
In this query we add a filter in line seven to restrict the output to non-gold standard data.
Since we have two gold standards as described in Section 3.3, we need to filter both. As
described in Section 5.4, the source of a disease-gene association can be identified by their
predicate. Thus we filter all entries whose relation is either disgenet or ncbigtr. The result
is a list of relation-gene tuples that co-occur with breast cancer.
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The extraction of all co-occurring diseases for the gene HSP27 (Tg=HSP27) works analo-
gously.
1 PREFIX c: cooccurrence
2 PREFIX g: gold
3
4 SELECT DISTINCT ?Dis ?Rel WHERE
5 {
6 ?Dis ?Rel <c:HSP27 > .
7 FILTER(?Rel != <g:disgenet > && ?Rel != <g:ncbigtr > )
8 }
Listing 5.9: SPARQL query to retrieve a list of co-occurring diseases for the specific gene
HSP27. The result is filtered to receive entries that do not belong to any gold standard.
The last query that is used extracts all co-occurrences for breast cancer and HSP27. Since
we already specified the disease and the gene, the result is simply a list of relations, which
is denoted as Td=breastcancer, g=HSP27.
1 PREFIX c: cooccurrence
2 PREFIX g: gold
3
4 SELECT DISTINCT ?Rel WHERE
5 {
6 <c:breast+cancer > ?Rel <c:HSP27 > .
7 FILTER(?Rel != <g:disgenet > && ?Rel != <g:ncbigtr > )
8 }
Listing 5.10: SPARQL query to retrieve a list of relations that connect the specific
diseases cancer with the specific gene LecB. The result is filtered to receive entries that
do not belong to any gold standard.
In the following, each feature group is described in detail by using the predefined sets.
We denote d ∈ D as the disease and g ∈ G as the gene of a given disease-gene pair to
which the features should be calculated.
Entropy
In an event that is determined by the co-occurrence of two variables, the entropy measures
the amount of uncertainty about the outcome of the event that remains when one variable
57
5 Approach and Resource Generation
is known. Following the definition of Shannon’s Entropy [57], we establish two formulas
that calculate the entropies for d, respectively g.
In the following equation, the calculation of the entropy H(d) for d is shown:
H(d) = −
G∑
g
pg(g, d) · log2(pg(g, d)) (5.11)
We define pg(g, d) as the probability at which g co-occurs with d within the data:
pg(g, d) =
|Tdg|∑G
g′ |Tdg′ |
The calculation of the entropy H(g) for the gene g works analogously as shown in Equation
(5.12).
H(g) = −
D∑
d
pd(d, g) · log2(pd(d, g))
pd(d, g) =
|Tdg|∑D
d′ |Td′g|
(5.12)
Two real world examples for INS and LecB are shown in Table 5.16. The first column
counts the number of diseases that co-occur with the gene. The second column shows the
corresponding entropy values. INS is a very frequent gene that co-occurs with more than
8.000 different diseases. The entropy shows a relative high value of 10.47. In contrast,
LecB co-occurs with only 7 different diseases. Its entropy value of 2.73 is rather small.
These values are consistent with the definition of Shannon’s entropy. A gene that co-occurs
with many different diseases has a high entropy and thereby leads to a high uncertainty.
More specific genes have small entropies and thereby low uncertainties to which disease
it could co-occur. This feature group is implemented to offer the possibility of balancing
the importance between rare and frequent genes, respectively diseases.
Mentioned Diseases Entropy
INS 8.853 10.47
LecB 7 2.73
Table 5.16: Example of the entropy for two different genes.
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Co-occurrence
The co-occurrence feature group describes the probability of a specific disease-gene pair
with respect to three different normalizations. The first feature value Occdg(d, g) is calcu-
lated by the number of co-occurrences between d and g and is normalized by the maximum
disease-gene co-occurrence that exists in the data:
Occdg(d, g) =
|Tdg|
max{|Td′ | : d′ ∈ D} (5.13)
The second feature Occd(d, g) value is normalized by the number of co-occurrences that
exist between the fixed disease d and any gene g′ ∈ G where g′ 6= g.
Occd(d, g) =
|Tdg|
|Td| − |Tdg| (5.14)
Analog to the second feature, the third one is normalized with respect to a fixed gene and
any disease d′ ∈ D where d′ 6= d.
Occg(d, g) =
|Tdg|
|Tg| − |Tdg| (5.15)
These features enable several points of view to the information that can be gained by the
specified disease-gene pair. The first feature Occdg(d, g) denotes the general strength of
their connection. The values range from zero to one. A value near to zero indicates a weak
connection, whereas a value near to one indicates a strong connection. The second and
third features define, similar to the entropy, the individual specificity of the co-occurrence
with respect to the disease respectively to the gene. The higher the value, the more
specific is the particular disease connected to the gene respectively the gene connected to
the disease.
Grades
The Grades feature group consists of two single features. The first feature counts the
number of triples that contain d. The second feature counts the number of triples that
contain g. Both values are normalized by their corresponding maximum value. Equation
(5.16) and (5.17) show the formulas to calculate both grade features.
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Graded(d) =
|Td|
max{|Td′ : d′ ∈ D} (5.16)
Gradeg(g) =
|T ′g|
max{|T ′g′ : g′ ∈ G′}
(5.17)
The grade feature is another way to express the frequency of an entity. The higher the
grade, the more frequent is the specific entity.
Odds Ratio
The odds ratio describes a statistical way to measure the dependency between two at-
tributes within a dataset. We use this feature to describe the dependency between d and
g. The first attribute A is defined as the presence or absence of d within a triple. The
second attribute B works analogously with respect to g. By observing these attributes, a
matrix can be set up with four elements as shown in Table 5.17. Each field in the matrix
counts the number of pairwise occurrence of the attributes.
B ¬B
A |Tdg| |Tdg| − |Tg|
¬A |Tdg| − |Td| |Tdiseases| − |Tdg|
Table 5.17: Odds ratio attribute matrix. With the two attributes A and B corresponding
to the presence or absence to the disease (A) respectively the presence or absence of the
gene (B).
The first field AB counts the number of triples in which the disease and the gene co-occur.
A¬B represents the number of co-occurrences where d co-occurs with any gene except
g. ¬AB can be interpreted analogously. The last field ¬A¬B contains the number of all
co-occurrences that neither contain the disease nor the gene.
To calculate the odds ratio, we use the formula defined in Equation (5.18).
Oddsgd(d, g) =
(AB) ∗ (¬A¬B)
(A¬B) ∗ (¬AB) =
|Tdg| ∗ (|T | − |Tdg|)
(|Tdg| − |Td|) ∗ (|Tdg| − |Tg|) (5.18)
In theory, the result is a number between zero and∞. However, since we have much more
triples that match ¬A¬B than the other three conditions, the odds ratio is either greater
than one or exactly zero. Thereby we interpret the value as follows: The higher the odds
60
5.5 Feature Extraction
ratio the higher, the dependency between d and g. A value of zero can only be reached if
the (AB-term) is zero, which means there is no dependency.
TF - IDF
The term frequency (TF) and the inverse document frequency (IDF) are measures that
are often used in the task of information retrieval from texts. From a given set of textual
documents, the TF-IDF is the information that can be gained from a word in a document
in order to classify the document. We adapted this way of information retrieval to the
problem of weighting a disease-gene association. By that, we do not define a document
as textual source, but as a disease that contains co-occurring genes. Thus, a term within
this document is defined as one co-occurring gene. By investigating the considered data,
we noticed a very high variance in the number of genes that are co-occurring with a
disease. Especially rare occurring diseases often only have a few co-occurring genes,
whereas frequently occurring diseases like cancer are mentioned with up to several hundred
genes. To avoid a bias towards longer documents (diseases that co-occur with many
genes), the term frequency is calculated by using the augmented normalization, which is
calculated as shown in Equation (5.19).
tfaug(g, d) = 0.5 +
(
0.5 ∗ |Tdg|
max{|Tdg′ | : g′ ∈ G}
)
(5.19)
The inverse document frequency is defined in Equation (5.20).
idf(g,D) = log(
|D|∑D
d f(d, g)
)
f(d, g) =

1 if |Tdg| > 0
0 else
(5.20)
The final feature value tfidf is then calculated as the product of the single components:
tfidf(g, d,D) = tfaug(g, d) ∗ idf(g,D) (5.21)
The final contribution to the feature vector are two features, namely the TF-IDF value
but also the IDF value separately.
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5.5.2 Gene Interaction Based Features
All previously described feature groups take a disease and a gene into account. The
next two feature groups, the Path Signatures and the Gene Connectivity are disease
independent and purely calculated on the gene-interaction network. Thereto, we define
Tgenes as a set of all triples in GID-DB.
Path Signatures
In this group, each feature represents a unique outgoing signature, as described in Section
5.3.2. Thereby, the number of possible features depends on both, the number of different
genes and the maximum path length respectively the maximum number of bridge-genes.
Since the number of possible features grows exponentially by increasing one of these two
factors, we set the maximum path length to two, respectively the maximum number of
bridge-genes to one. The limitation of the number of genes cannot be restricted that
easily. In fact, there are only two ways to reduce the number of genes effectively. The
first and most important reduction is done by an effective gene-normalization framework.
An other way is to reduce the genes by limiting the taxonomic scope. This could be
for example a limitation to human genes as we did it in this work. On the one hand,
each limitation could lead to missing a significant structure in the data, which could
easily have a negative effect on the final results. On the other hand, some limitations
and assumptions need to be made in order to reduce the processing time or to focus the
results to the desired scope. A well defined purpose of the data usage is thereby crucial
and should be done very carefully in the first place.
The signature-feature value depends on two variables, a gene g and a signature s. The
actual value is defined by the TF-IDF value of the term s within the document g as
shown in the equations (5.22), (5.23) and (5.24). We define Sout(g) as a list of all outgoing
signatures (as described in Section 5.3.2) for the specified gene g. Notice that, due to the
fact that the signature are gene-independent but not their generation, these lists could
contain any signatures multiple times.
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The basic idea of these features is to find one or more specific signatures, that may identify
an important relation between a gene that is already known as disease-related and a new
gene. Currently, only the outgoing signatures are considered in this feature group, since
we assume that outgoing signatures contribute more relevant information. In a further
improvement of the system, we should extend these features by incoming signatures as
well.
tfidfsig(s, g,G) = tfsig(s, g) ∗ idfsig(s,G) (5.22)
tfsig(s, g) =
∑Soutg
s′ f(s, s
′)
max{∑Sout(g)s′ f(s, s′) : s ∈ Sout(g)}
f(s, s′) =

1 if s = s′
0 else
(5.23)
idfsig(s,G) = log(
|G|∑G
g f(g, s)
)
f(g′, s) =

1 if s ∈ Sout(g′)
0 else
(5.24)
Gene Connectivity
The last feature group describes the connectivity of a gene within the gene-network graph.
This group contains four different types of features. The number of single features depends
on the maximum number of bridge-genes. The first features count the number of outgoing
signatures for each length separately. The next features count the number of incoming
signatures for each length separately. The last two features, represent the arithmetic
mean, respectively the ratio of the previous features.
To calculate these features we denote Sin(g, l) as a list of all incoming signatures and
Sout(g, l) as a list of all outgoing signatures with the specific path length of l. Further, we
denote L as the maximum path length where l ≤ L . The query to extract all outgoing
signatures for a specific gene e.g. HSP27 is similar to that one defined in Listing 5.2. The
only difference is that we do not specify a theme-gene. The query to create Sout(g, l = 2)
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for HSP27 is shown in Listing 5.11.
1 PREFIX e: event
2 SELECT ?OutRel1 , ?OutRel2 WHERE
3 {
4 <e:HSP27 > ?OutRel1 ?BridgeGene1 .
5 ?BridgeGene1 ?OutRel2 ?GeneTheme1 .
6 }
Listing 5.11: SPARQL query to retrieve a list of all outgoing relations for the cause-gene
HSP27.
These extracted relations can be used to generate an outgoing signature by following the
description in Section 5.3.2. The generation of Sin(g, l = 1) is analogously. Listing 5.12
shows an example query to retrieve all incoming signatures for the specific theme-gene
HSP27.
1 PREFIX e: event
2 SELECT ?InRel WHERE
3 {
4 ?CauseGene ?InRel <e:HSP27 > .
5 }
Listing 5.12: SPARQL query to retrieve a list of all incoming relations for the theme-gene
HSP27 with a length of 1.
The first feature Outnorm(g, l) and the second feature Innorm(g, l) can be calculated as
shown in the following equations:
Outnorm(g, l) =
|Sout(g, l)|
max{|Sout(g′, l)| : g′ ∈ G} (5.25)
Innorm(g) =
|Sin(g, l)|
max{|Sin(g′, l)| : g′ ∈ G} (5.26)
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The third feature, Presence(g) represents the normalized mean value and is calculated
by:
Presence(g) =
Out(g) + In(g)
max{(Out(g′) + In(g′′)) : g′, g′′ ∈ G}
Out(g) =
L∑
l
|Sout(g, l)|
In(g) =
L∑
l
|Sin(g, l)|
(5.27)
In all three features, the values range from zero to one. The higher the value, the higher
the connectivity of g in the network.
The fourth feature IORatio(g) is defined by the ratio between the incoming and outgoing
number of signatures. The ratio is defined as:
IORatio(g) =
max(1, Out(g))
max(1, In(g))
(5.28)
If the result is greater than one, the gene has more outgoing edges and has a rather
manipulating role in the gene network. In contrary, if the number is less than one, it
indicates that the gene is more manipulated by other genes. If the specific gene does not
have either an outgoing or an incoming signature, we set the corresponding value to one.
Thus, a division by zero is avoided. With a maximum path length of two, this feature
group has six features that contribute information about the gene-connectivity.
5.5.3 The Feature Vector
In the previous subsections, we formalized all features and explained their generation and
calculation in detail. In this subsection, the composition of the feature vector is described.
1. Entropy : SVentropy - The sub vector for the Entropy is a two dimensional vector:
SVentropy(d, g) =
H(d)
H(g)
 (5.29)
The values are calculated by Equation (5.11) and (5.12).
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2. Co-occurrence : SVcooc - The sub vector for the Co-occurrence is a three dimensional
vector:
SVcooc(d, g) =

Occdg(d, g)
Occd(d)
Occg(g)
 (5.30)
The values are calculated by Equation (5.13), (5.14) and (5.15).
3. Grade : SVgrade - The sub vector for the Grade is a two dimensional vector:
SVgrade(d, g) =
Graded(d)
Gradeg(g)
 (5.31)
The values are calculated by Equation (5.16) and (5.17).
4. Odds Ratio : SVodds - The sub vector for the Odds Ratio is a one dimensional vector:
SVodds(d, g) =
(
Oddsgd(d, g)
)
(5.32)
The value is calculated by Equation (5.18).
5. TF-IDF : SVtfidf - The sub vector for the TF-IDF is a two dimensional vector:
SVtfidf (d, g) =
tfidf(g, d,D)
idf(g,D)
 (5.33)
The values are calculated by Equation (5.20) and (5.21).
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6. Gene Connectivity : SVconnectivity - The Gene Connectivity sub vector with a maxi-
mum path length of two is a six dimensional vector:
SVconnectivity(g) =

Outnorm(g, 1)
Outnorm(g, 2)
Innorm(g, 1)
Innorm(g, 2)
Presence(g)
IORatio(g)

(5.34)
The values are calculated by Equation (5.25), (5.26), (5.27) and (5.28).
7. Path Signatures : SVsignatures - The dimension of the sub vector for the Path Signa-
tures depends on the considered genes and the maximum path length. The latter
variable needs to be defined in the first place and must not be changed anymore.
The maximum path length was set to two. The genes were restricted to those,
who occur in the currently used gold standard. The features for the Path Signa-
tures group were then aggregated for each of those genes. Given Ggold defined as
a set of all genes that occur in the gold standard, the total amount of different
signatures/features denoted as Fsig is calculated as:
Fsig = {Sout(g, l) : g ∈ Ggold, l ≤ L} (5.35)
Thereby, the sub vector for the Signatures is a n dimensional vector, where n =
|Fsig|:
SVsignatures(g) =

tfidfsig(Fsig[0], g)
tfidfsig(Fsig[1], g)
tfidfsig(Fsig[2], g)
...
tfidfsig(Fsig[n− 1], g)

(5.36)
The values are calculated by Equation (5.22).
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The final feature vector FV for a given disease d and a given gene g is then a composition
of all sub vectors:
FV (d, g) =

SVentropy(d, g)
SVcooc(d, g)
SVgrade(d, g)
SVodds(d, g)
SVtfidf (d, g)
SVconnectivity(g)
SVsignatures(g)

(5.37)
with a total of 14 + |Fsig| dimensions.
5.6 Summary
In this chapter, we discussed the most important methods that we use in our approach.
In Section 5.1 we described the disease extraction pipeline. This pipeline consists of two
consecutive methods, the disease mention recognition and the disease normalization. We
integrated a CRF tagger by Klinger [36] as disease recognition. In Section 5.1.2, we
introduced DiNo, a simple disease normalization framework. We evaluated the entire
pipeline on the NCBI disease corpus [23] and archived an F-score of 61.79%.
The gene event extraction pipeline was discussed in Section 5.2. The pipeline starts with
the event extraction system TEES [9]. All genes that are found by TEES are normalized
by GeNo [72]. We evaluated the combination of both state-of-the-art systems on the
BioCreative-II gene normalization corpus [46]. The usage of TEES as gene recognition
model for GeNo yields a performance of 55.33%. During the normalization, we discarded
all genes that did not belong to the human species. We use EntrezGene [45] to accomplish
this filtering by comparing the taxonomic IDs.
By that, we heavily reduced the amount of considered genes and events. On top of that,
we transformed the remaining complex gene-events into simpler sub-events, describing a
relation between two genes. After an extensive graph transformation, the relations were
then simplified and normalized in order to reduce their complexity. The entire process of
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event graph generation was described in Section 5.3. For the task of feature generation,
we defined a Path Signature as modified consecutive relations between two genes in the
gene-interaction network. The process of signature generation was described in Section
5.3.2.
Based on the gold-standard data, which was introduced in Section 3.3, and the extracted
diseases, genes and gene-events, we store three different types of RDF-quadruple in two
different databases. The first kind of triple covers an abstract-based co-occurrence of a
disease and a gene. The next type of triple contains a disease-gene association from the
gold data. Both types of triples were stored together in the Disease-Gene-Association
database. The third type of triple covers a simplified gene-event. By integrating all ex-
tracted gene-events into a graph database, we generated a comprehensive gene-interaction
network where genes are nodes and their relations are expressed through edges. We store
the third type of triple in a separate database called Gene-Interaction-Network database.
The triple generation and storage were described in Section 5.4.
In Section 5.5, we formalized the features that we used to train machine learning mod-
els. We distinguished between features that are based on the Disease-Gene-Association
database and those that are based on the Gene-Interaction-Network database. The first
kind included the following five features: Entropy, Co-occurrence, Grade, Odds Ratio and
TFIDF. These features take a specific disease and a specific gene into account. The sec-
ond kind of features are disease independent and are calculated on the gene-interaction
network. These are: Path Signatures and Gene Connectivity. The chapter ends with a
comprehensive view on the final feature vector that can be generated for any disease-gene
pair using the presented methods in this chapter.
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This work describes a system for disease-gene association extraction, with respect to the
identification of undiscovered public knowledge. We addressed this task by building and
analyzing a gene-interaction network. The aggregation of information of gene-interactions
that goes beyond the scope of a single abstract, allows us to generate novel disease as-
sociated gene candidates. Using concept-interaction networks to find hidden knowledge,
often leads to a high number of novel candidates. In order to deal with this problem, we
implement two different methods. In the first method, we train a support vector machine
to classify a gene-candidate as disease related or not. In our second method, we train a
support vector regression to rank gene-candidates by their importance to a disease. Both
methods have advantages and disadvantages, which will be described in the following
experiments. However, both methods offer the possibility to limit the amount of novel
candidates and focus the attention to the most important.
So far we have discussed:
1. the materials that we used for the information extraction in Chapter 3.
2. the system architecture in Chapter 4 that gives an insight of the resource generation
pipeline.
3. the most important methods of the resource generation in detail. And we formalized
various features to define the feature space, in Chapter 5.
In this chapter, we present several experiments to test the performance of our system. In
the first section (Section 6.1), we describe the experiments we have made to find the best
classification model. We trained various models that were built with different features-sets
and evaluate them on a test set. In Section 6.2, we describe experiments to find the best
regression model. On top of that, we integrate the best performing regression model of the
training data into our system, and pre-evaluate the ranking task on a test set. In a last
experiment, presented in Section 6.3, we examine our system’s performance with a case-
study. We use Pulmonary Fibrosis as testing disease and generate 200 gene-candidates,
which were evaluated by biomedical experts.
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During the case-study, we want to prove the following assumption:
(6.1) We assume that a gene-interaction network, such as we built in Section 5.3,
contains reliable features that contribute useful knowledge, which can be learned by
machine learning methods, to enhance the quality of the generated output.
6.1 Classification of Genes Candidates
In this section, we describe the general experimental setup from our experiments, finding
the best performing classification model. This includes a description of the training and
test set, the measurement and a brief overview of the used machine learning method. In
Section 6.1.2, we present and discuss the evaluation results. The main objective of these
experiments was to find the best performing model that represents the Genetic Testing
Registry-gold data, with respect of our assumption in Example 6.1.
6.1.1 Methods and Experimental Setup
Classification with Support Vector Machine In this work, we use a standard soft-
margin Support Vector Machine [19] for classification (C-SVM), and use the well estab-
lished Gaussian-kernel function, also known as Radial Basis Function (RBF), to deal with
data that is not linear separable. The C-SVM is a common supervised machine learning
method for binary classification. It classifies a data point x ∈ IRn by assigning a class
label y ∈ {−1, 1}. Given a labeled training set of N data points {(xi, yi)|i ∈ N}, the
goal of the C-SVM is to find a hyper-plane that separates binary-labeled data points with
a minimum of false classifications and a maximum generalization. The efficiency of our
C-SVMs depends on the choice of two parameters: the gamma parameter of the RBF
and the soft-margin parameter C of the C-SVM. The actual implementation of an SVM
was provided by LibSVM [15], which can be integrated into the WEKA-environment. For
more information, we refer to [19,63].
Meta Parametrization To optimize the classification results, we adjust the two param-
eters gamma and C:
• C is the parameter for the soft-margin cost function. It controls the influence of
each individual support vector that defines the hyper-plane. A larger C aims at
classifying all training examples correctly. By that, the SVM is able to select more
training points as support vectors, which leads to a high variance due to penalizing
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miss-classifications a lot. A lower C allows the SVM to ignore miss-classified data
points with respect to finding the maximum margin.
• gamma is the parameter of the Gaussian kernel function to handle non-linear clas-
sifications. It defines the influence of each training point to the hyper-plane. A low
gamma leads to a far reach, a high gamma leads to a close reach.
C and gamma cannot be determined independently. Thus, to find the best trade-off
between a large margin and a small error penalty, we perform a grid search within a fixed
boundary for both parameters. We use the integrated grid-search function in WEKA [29],
to select the best pair between 0.1 and 10000 (exploring in decimal powers).
Feature Reduction Besides the meta parametrization, we reduce the feature space to
improve the classification and speed up the process. A common way to do this is to deter-
mine the Information Gain [37] (IG) for each feature, to rank them by their importance
and chose only the best ones. The IG evaluates the worth of a feature with respect to its
class as shown in the following equation, where H denotes Shannon’s Entropy [57]:
IG(class, feature) = H(class)−H(class|feature) (6.2)
The IG can be interpreted as the reduction of the uncertainty of the prediction by taking
a given feature into account. That means, the higher the value, the more worthy the
feature. We used the integrated WEKA-function to calculate the IG, to get a list of
features sorted by their worthy. We use the IG to extract the best n features, where
n variates during the experiments, and thereby reduce the dimensionality of our feature
space to n.
Macro Average F-Score The experimental results are measured and compared by de-
termining the precision, recall and (harmonic mean) F-Score, which were calculated as
follows:
p =
true positive
true positive + false positive
r =
true positive
true positive + false negative
f = 2 · p · r
p + r
(6.3)
We defined the number of true positives as all genes that were classified correctly as related
to the specific disease. The false positives and false negatives are defined analogously. In
these experiments, we consider the macro average results to evaluate the performance of
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the models. To determine the macro average results, the precision, recall and F-Score is
calculated separately for each disease. Subsequently, the arithmetic mean is built over all
diseases.
The Training and Test Set As mentioned before, we train a C-SVM to classify genes
as disease related or not. Thereto, a training and a test set is created, using the Genetic
Testing Registry as gold-standard data. All disease-gene associations in GTR are human
curated. Thus, we assume that each association represents a positive data example. We
labeled all associations from the gold-standard with the class value 1. For each disease in
GTR, we then extract gene-associations from our previously built disease-gene-association
database (see Section 5.4), hereinafter referred to as DGA-DB, to extract almost the same
amount of negative training examples. A disease-gene-association within DGA-DB is a
negative training example, if and only if the association is not mentioned in GTR. All
negative examples are labeled with the class value -1. Once the positive and negative
training examples are extracted, we divide the data into an 80-20 split. We use 80% as
training data and 20% as test data. The training data consists of 3.665 data points with
1.781 negative and 1.884 positive examples. The test set consists of 910 data points with
440 negative examples and 470 positive examples. To ensure comparable results during
the evaluation of the different models, we fixed these training and test sets.
6.1.2 Evaluation Results and Discussion
Our experiments on the classification models are separated into two parts. In the first
part, we evaluate the models on the training data, using a ten-fold cross validation. The
objective of this pre-evaluation is to extract the best and interesting models. These will
be evaluated against the test set and will later be integrated into the entire pipeline. Each
model contains a different compositions of features. They can be separated into Feature
Group-models (FG), Best N Signature Features-models (BSF) and Best M Features-
models (BMF). In Table 6.1, we compare all models in FG among themselves. Table
6.2 shows the results of all evaluated BSF models. Table 6.3 compares all models in
BMF. Finally, the best models from each model group are compared with our baseline
model on the test set. The results are shown in Table 6.4.
Feature Group Models A model in FG contains exact one feature group that was
described in Section5.5. Beyond those single-feature-group models, FG includes a model
that takes all co-occurrence based features into account (CBF) (as described in Section
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5.5.1), and a model that takes all co-occurrences based features in combination with the
gene-connectivity features (CBF+Connectivity) into account. We evaluate all models in
FG, performing a ten-fold-cross validation on the training data. The results are presented
in Table 6.1.
Feature Group Precision Recall F-Score
Entropy 64.1 62.9 63.5
Co-occurrence 88.1 71.9 79.2
Grade 58.4 82 68.2
Odds Ratio 80.7 28.8 41.8
TF-IDF 91.3 65 75.9
Path Signatures 62.9 79.8 70.3
Connectivity 60.8 70.1 65.1
CBF 91.1 76.6 83.2
CBF+Connectivity 89.7 79.8 84.5
Table 6.1: Evaluation results of the FG-classification models on the training data using a
ten-fold cross validation. The highest value for precision, recall and F-Score is highlighted.
The Entropy reaches an F-Score of 63.5% with a precision of 64.1% and a recall of 62.9%.
The Co-occurrence-model is the best performing model that uses a single feature group,
with an F-Score of 79.2%, which is a composition of the high precision of 88.1% and a
stable recall of 71.9%. We assume that the high performance of the co-occurrence is mostly
determined by the chosen gold-standard. Since all gold-associations were human curated,
we assume that most of them are already published, which leads to a bias towards the
Co-occurrence. The Grade yields the lowest precision with 58.4%, but the highest recall
of 82%. The Grade feature takes the disease and the gene separately into account. We
assume that this influences the precision negatively. Since the Grade simply counts the
number of occurrences in the database, the high recall is maybe given through a low
occurrence-threshold. In contrast to this is the Odds Ratio, which yields a high precision
of 80.7%, but lacks at the recall (28.8%). Its F-Score of 41.8% is the lowest of all feature
groups. The TF-IDF reaches the highest precision with 91.3%, and is thereby 3.2 points
higher than the Co-occurrence. The relatively low recall of 65% leads to the second highest
F-Score of 75.9%. The performance of the Path Signature model reaches an F-Score of
70.3%, which is, in comparison to the other results, on average. The evaluation of the
Connectivity model results in an F-Score of 65.1% with a precision of 60.8% and a recall
of 70.1%, which is a very stable result, too.
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A conspicuous behavior can be extracted from these results. We noticed that features,
which take the disease and/or the genes separated into account, rather lead to a higher
recall. This can be seen in the Grade, Path Signatures and Connectivity feature group.
The other four feature groups rather lead to a higher precision.
The comprehensive co-occurrence based model, CBF, reaches a very high precision of
91.1% and a moderate recall of 76.6%, which leads to an F-Score of 83.2%. The com-
bination of all co-occurrence based features outperforms each model that is based on a
single feature group. However, the addition of gene-connectivity features increases the
performance at 1.3 points and is thereby the best performing model in FG. The F-Score
of 84.5% is a composition of the slightly lower precision of 89.7 and the 2.8 points higher
recall of 79.8%.
Best N Signature Feature Models A model in BSF is determined through the best
N Path Signature-features (see Section 5.5.2) according to their IG. Based on their IG,
four models were built with increasing number of features. Our BSF-experiments started
with a model that contains the best 50 Path Siganture-features, namely Best50Signatures.
All other model-names in BSF can be interpreted analogously. We evaluate four models
in BSF by performing a ten-fold-cross validation on the training data. The results are
presented in Table 6.2.
Model Setup Precision Recall F-Score
Best50Signatures 55.7 84.2 67.1
Best90Signatures 57.0 83.0 67.6
Best140Signatures 57.9 83.3 68.3
Best190Signatures 58.1 82.3 68.1
Table 6.2: Evaluation results of the BSF-classification models on the training data, using
a 10-fold cross validation. The highest value for precision, recall and F-Score is highlighted.
The Best50Signatures-model reaches an F-Score of 67.1% with a precision of 55.7% and
a recall of 84.2%. Taking 90 features into account, shows an increasing precision and a
decreasing recall. The model Best90Signatures performs with a precision of 55.7% and
a recall of 83%, which results in an F-Score of 67.6%. A similar behavior can be seen
by increasing the number of features to 140. The precision increases to 62.7%, while
the recall drops to 70.3%. The Best140Signature-models reaches an F-Score of 66.3%.
The last tested model, the Best190Signatures, pursues this trend. It reaches the highest
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precision of all tested models in BSF with 83.2%, but the lowest recall of 57.1%. In all
tested models in BSF, we recognized an almost constant F-Score of 67.7%S (+-0.6).
Best M Feature Models A model in BMF contains the best M features, according
to their IG, regardless of the feature group, which leads to a large overlap to the BSF
models. However, in this results, we can see the impact of co-occurrence-based features.
The models in BMF are named analogously to the models in BSF. We evaluate them by
performing a ten-fold-cross validation on the training data. The results are presented in
Table 6.3.
Model Setup Precision Recall F-Score
Best20 91.1 73.8 81.5
Best50 90.8 73.7 81.4
Best100 88.9 74.5 81.1
Best150 87.5 76.9 81.8
Best200 87.5 76.8 81.8
Table 6.3: Evaluation results of classification model on the training data, using a ten-fold
cross validation. The highest value for precision, recall and F-score is highlighted.
The first model, Best20, reaches a precision of 91.1%, a recall of 73.8% and thereby an
F-Score of 81.5%. By adding the next 30 best features, the precision and recall slightly
decrease at 0.3 points, respectively 0.1 points. This trend can be pursued in the next three
model evaluations. The more features we added, the lower the precision, the higher the
recall. However, all evaluated models have an almost constant F-Score of 81.4% (+-0.4
points).
Evaluation on Test Set In Table 6.1, we saw that the co-occurrence based feature
rather leads to a high precision. In Table 6.2, we saw that increasing the number of
signatures leads to a decreasing precision, while the recall increased. A similar (but
inverted) behavior could be recognized in the last experiments in which we took all types
of features into account. The result was shown in Table 6.3. All described experiments
so far, were done, suing a ten-fold cross validation on the training set.
In our last classification-experiment, we evaluate the best models from the previous ex-
periments on the test set against our baseline model. We choose the pure document based
disease-gene co-occurrence as baseline. Thus, our baseline-model contains just a single
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feature: the co-occurrence as defined in Equation (5.13). We evaluate all models on the
test set. The results are presented in Table 6.4.
Setup On Test Set Precision Recall F-Score
Baseline 89.8 57.9 70.4
Best150 87.0 78.1 82.3
Best190Signatures 59.6 81.1 68.7
CBF+Connectivity 86.9 81.9 84.3
CBF 92.1 78.8 85.0
Table 6.4: Evaluation results of the best performing classification-models on the test set
in comparison with the baseline-model. The highest value for precision, recall and F-score
is highlighted.
Similar to the Co-occurrence-model in our first experiments, the baseline is clearly stronger
in the precision with 89.8%. However, due to the miss of both other features in Co-
occurrence (see Section 5.5, second paragraph), the recall stays at 57.9% in the baseline
and got an relatively high F-Score of 70.4%. The Best150 model performs similar to its
evaluation on the training set. The precision is at 87.0%, the recall at 78.1% (slightly
higher than on the training set) and it has an F-Score of 82.3%. Thereby, this model out-
performs the baseline at 12.1 points. The Best190Signatures-model lacks in the precision
(59.6%), but has a very high recall with 81.1%, which results in 68.7% F-Score and can-
not reach the performance of our baseline. The evaluation of the Co-Connectivity-model
shows very stable results in precision (86.9%) and recall (81.9%). The results are similar
to the evaluation on the training data with a slight drop in precision and an increased
recall. It reaches a performance of 84.3% in F-Score. The removal of the gene-connectivity
features leads to a higher precision and lower recall. The CBF -model performs at best
with 85.0% in F-Score with a precision of 92.1% and a recall of 78.8%.
Summary By investigating the evaluation results, we can extract several striking results:
1. Features, that are based on the gene-interaction network, rather lead to a higher
recall instead of high precision.
2. On the contrary, disease-gene co-occurrence based features rather lead to a higher
precision instead of high recall.
3. If a model contains solely Path Signature-features, increasing the number of signa-
tures leads to an increasing precision and a decreasing recall.
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4. In hybrid models, increasing the number of signature-features leads to a decreasing
precision and an increasing recall.
5. The best result on the test set can be achieved by discarding all non-co-occurrence
features. We assume that this is mainly given due to the fact that all positive
associations from the gold-standard (GTR) were already published, which creates
a bias towards co-occurrence based features. If we are interested in mapping the
gold-standard most accurately, this is the best model to do it. However, this may
not be the best model to find novel disease-gene associations .
6. We were able to outperform the baseline-model at 14.6 points in F-Score.
6.2 Ranking of Gene Candidates
In this section, we present the evaluation results of our experiments, regarding to the
task of gene candidate ranking. In the following sub-section, the general methods and
experimental setups is described. In Section 6.2.2, we present and discuss the evaluation
results. The main objective is to find the best performing model that represents the
DisGeNET -gold standard with respect to our assumption in Example 6.1.
6.2.1 Methods and Experimental Setup
Ranking with Support Vector Regression In the previous task we used an SVM for
binary classification. In the following experiments we need are machine learning method
that assigns a numerical value to a new data point. With these regression-values we are
able to sort/rank a gene-list. In the following experiments a Support Vector Regression
(SVR) is used. The SVR is a special case of an SVM and it shares the basic concepts
of finding the best fitting hyperplane that maximizes the margin, and minimizing the
error. To deal with non-linear separable data, we use the Gaussian-kernel function. In
addition it has a third parameter called epsilon which can be seen as a margin of tolerance.
The performance of an SVR depends on three parameters, the cost-function parameter
C, the kernel-parameter gamma and the tolerance parameter epsilon. In this work a
standard ε-SVR is used which was provided by LibSVM [15], integrated into the WEKA
environment. For a detailed description we refer to [61] and [15].
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Meta Parametrization Likewise to the SVM optimization, the performance of an SVR
depends on the cost-function parameter C and the kernel Parameter gamma. In addition,
a third parameter needs to be optimized, namely the epsilon (ε).
• The ε-parameter determines the width of the ε-decision-boundary, which is used to
fit the training data. The higher ε is chosen, the less support vectors can be used
to build the regression function. Higher ε-values also increase the ’flatness’ of the
regression function.
The best value-combination of the three parameters can be determined in an advanced
grid-search. To do so, we use the WEKA-integrated grid-search method [29], similar to
the determination in the classification task.
Feature Reduction For the classification, we estimated the best features by determining
the features- information gain. However, the IG can only be calculated for nominal class
values. A regression-method assign and uses numeric class values, which denies us to use
the IG. Instead, we use the Correlation Feature Selection to estimate the best subset of
features. The CFS-method [30] determines the best subset with respect to the correlation
of the features within the current subset and their correlation to the classification. The
higher the features are correlated to the classification, the higher is the worth of the subset.
In addition, the higher the correlation between the features in the subset, the lower is the
worth of the subset. We use the WEKA-integrated CFS-method to determine the subset
with the highest merit.
Measurements for Regression Experiments To measure and compare the results of the
gene-ranking evaluation, we use the Mean Reciprocal Rank [20,70] (MRR). We determine
the Correlation Coefficient (CC) and compare the Mean Absolute Error (MAE) / Root
Mean Square Error (RMSE). CC, MAE and RMSE are standard measures of a regression.
Thus, we do not further explain them here, but refer to [29, 30, 41] or [61] for more
information.
The MRR is an algorithm to measure the quality of a ranking approach according to
a set of queries. In contrary to the standard F-Measure, the MRR is calculated with
respect to the order of the results. Thereto, it compares the order of a ranking system,
which produces a sorted list of elements, to a gold-list of elements. The MRR is always
calculated for a set of queries and builds the arithmetic mean of the reciprocal rank as
shown in Equation (6.4).
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MRR =
1
N
∗
D∑
d
1
rank(Gd, rd0)
(6.4)
N is the number of diseases (queries) to evaluate, calculated as N = |D|. Gd is the gold-
list of genes (elements) for the specific disease d, and rd0 is the first gene in the result-list
that was created by the ranking-system for the disease d. The function rank(G, r) returns
the index of the element r in the gold-list, if it exists, or zero and is defined as follows:
rank(G, r) =

index of r in G if exists
0 else
(6.5)
Training and Test Set To train the SVR-models, we need a training and test set,
similar to the classification sets. However, they differ in one important fact. While the
classification sets contain binary labeled data points, the regression deals with numerical
labels. Thus, we choose DisGeNET (see Section 3.3) as gold-standard-data. DisGeNET
provides a confidence score for each disease-gene association. In order to reduce the
number of training and test data points, and to decrease the amount of false positive data
points1, we choose only those associations as positive examples, whose confidence score
is greater than 0.1 (see footnote2). After extracting all positive training examples from
DisGeNET, we extract almost the same amount of negative examples from our database.
A disease-gene-association within DGA-DB is a negative training example, if and only if
the association is not mentioned in DisGeNET. All negative training examples get the
class-value 0. As we did it before, our extracted positive and negative training data are
divided into an 80-20 split. We use 80% as training data and 20% as test data. The
training data consists of 25.294 data points, split into 11.658 negative and 13.636 positive
data points. The test data contains 6.320 data points, split into 2.912 negative and 3.608
positive data points. To ensure comparable results during the evaluation of the different
models, we fixed these training and test sets.
1The associations in DisGeNET are not human curated but extracted automatically. Thus, the there is
no 100% evidence for each association.
2The threshold of 0.1 was motivated by the confidence-scoring function of DisGeNET.
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6.2.2 Evaluation Results and Discussion
Our experiments on the ranking-models are separated into three parts. At first we evaluate
some models on the training set, using a ten-fold-cross validation. During the training, we
adjust the meta parameter and do some feature-setting experiments. The goal of the pre-
evaluations is to find the best models and settings, which are then tested against the test
set. Both steps are similar to the classification-experiments. Due to the combination of
the high number of training examples, conducting an experiment is very time consuming.
However, our feature-reduction-method CFS aims at optimizing the CC, which is also
one of our key-measures. This allows us to reduce the experiments of feature-variations
without too much loss of information. We assume that the used CFS-method returns
the subset of features that maximizes CC. With respect to the MAE and RMSE, we
investigate a few more models on the training set. All results of the evaluated models are
shown in Table 6.5.
In the second part, we evaluate the best performing and most interesting models on the
test set. The results are shown in Table 6.6. Similar to the first part, we measure the
results with respect to the CC, MAE and RMSE. The models are also compared to our
baseline-model.
In the third part, we evaluate the same models from part two, but in a different way.
Thereto, each of these models (which were previously build on the training data) is inte-
grated into the ranking-system. We then apply all diseases from the test set to the system,
which generates a sorted result-list of genes. We compare the result-lists for each disease
to the corresponding gold-list, by calculating the reciprocal rank. Finally the MRR can
be determined for each model. The evaluation results of these experiments are shown in
Table 6.7.
Evaluation on Training Set We evaluate several models on the training data, using a
ten-fold-cross validation. The main objective was to find the best meta parameter and
the best performing models. We show the best evaluation results in Table 6.5.
The first model that was tested on the training data consists of the best subset, which was
generated by the CFS-method. We called this model CFS328. Using this feature subset,
the model leads to a CC of 0.5663. The performance reaches a MAE of 0.1224 and a
RMSE of 0.1426. The high CC does not automatically lead to a low MAE/RMSE. Thus,
we evaluate the Co-occurrence Based Feature-model (CBF) and the Co-occurrence based
Features + Gene Connectivity Features-model (CBF+Connectivity). The CBF shows a
CC of 0.5480 and a MAE of 0.1213, which is slightly better, and a RMSE of 0.1457, which
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Setup On Training Set CC MAE RMSE
CFS328 0.5663 0.1224 0.1426
CBF 0.5480 0.1213 0.1457
CBF+Connectivity 0.5709 0.1146 0.1437
CFS399Sig 0.038 0.1475 0.1814
Table 6.5: Evaluation results of regression model on the training data, using a ten-fold
cross validation. The highest value for CC, MAE and RMSE is highlighted.
is slightly worse than the performance of the CFS328 -model. By adding the Connectivity-
features, surprisingly, we reach the highest CC of all tested models. It shows 0.5709 points.
The MAE shows the lowest error so far with 0.1146. However, the RMSE with 0.1437 is
between the CFS328 -model and the CBF -model . Finally we tested the best CFS-model
with the restriction to Path Signature-features, namely CFS399-Sig. It leads to almost
no correlation in the data points. The CC is at 0.038 and the performance shows a MAE
of 0.1213 and a RMSE of 0.1475 .
Evaluation on Test Set We evaluated some of the previous generated models against
the test set and compare our result with our baseline-model. Likewise to the classification-
experiments, our baseline-model only takes the pure co-occurrence into account, as defined
in Equation (5.13). The results are presented in Table 6.6.
Setup On Test Set CC MAE RMSE
Baseline 0.4358 0.1344 0.1609
CFS328 0.5806 0.1249 0.1453
CBF+Connectivity 0.5831 0.1164 0.1454
Table 6.6: Evaluation results of regression-model on the test data. The highest value for
CC, MAE and RMSE is highlighted.
Our baseline-model shows with 0.4358 the lowest CC of all tested models . It performs
with an MAE of 0.1344 and an RMSE of 0.1609. The baseline is slightly outperformed by
both tested models. The CFS328 -model shows a data correlation of 0.5806. The MAE
drops at 0.0095 to 0.1249. The RMSE drops to 0.1453. The CBF+Connectivity-model
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shows a slightly higher correlation with 0.5831, the lowest MAE of 0.1164 and almost the
same RMSE like the CFS328-model of 0.1454.
According to the evaluation results, we assume that gene-ranking is a more difficult or
complex task than gene-classification. In the classification experiments, we showed that a
C-SVM is able to learn, with an F-Score of over 80%, whether a gene is related to a disease
or not. Since the SVR and the SVM share the same basic concepts, we assume that the low
results of the ranking experiments are affected by the chosen gold-standard. In contrast
to GRT, DisGeNET is generated automatically, using various methods. Thus, it may
includes some false positive training examples, which may have affected the correlation of
the data negatively, if a correlation exists. In further experiments with less training data,
by increasing the confidence threshold, this behavior should be investigated. However,
this goes beyond the scope of this thesis and is left for future work.
Evaluation of the Ranking System In our last ranking-experiment, we evaluate our
system by integrating the previously described models into our system. For each model,
we apply all diseases in the test set to our ranking-system, which creates a ranked list of
genes for each disease. We compare the result-lists to the corresponding gold-list, which
is created with the positive data points of the test set. The results are shown in Table
6.7.
Model MRR
Baseline 0.6909
CFS328 0.7067
CBF+Connectivity 0.6816
Table 6.7: Evaluation results of the system by integrating a model.
Integrating our baseline-model leads to a Mean Reciprocal Rank of 0.6909. It is slightly
outperformed by the CFS328 -model with an MRR of 0.7067. Although, the CBF+Connectivity-
model showed slightly better results in the evaluation on the test set, its MRR shows the
lowest result with 0.6816.
Summary By investigating the evaluation results, we noticed the following things:
1. The highest data correlation can be observed by using the CBF+Connectivity-
model. However, it reaches a CC of just 0.5831. We assume that the low data
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correlation is somehow affected due to the chosen gold-standard and its resource
generation.
2. The best subset that can be extracted, using only Path Signature-features leads
to almost no correlation between the data. The CC is at 0.0375. In addition, it
had the lowest performance of all tested models with 0.1213 in MAE and 0.1475 in
RMSE. By taking all features into account, the best subset shows a slightly better
performance of 0.1453 in RMSE. This displays the high influence of co-occurrence
based features.
3. We were slightly better than the baseline-model on the test set with a drop in RMSE
of 0.0146, and an increased MRR of 0.01. The comparison emphasizes again the high
influence of the co-occurrence feature. Likewise to the results in the classification
experiments, this can be partly explained, due to the exposure of positive results
of disease-gene association results. However, the significance of the improvements
needs to be determined in further experiments.
6.3 Case Study with Pulmonary Fibrosis
In the previous both experiments, we evaluated the trained models that should finally be
integrated into the system. We determined the best meta parameter and feature selection
for the classification and the ranking task. With the information that could be extracted
from the previous experiments, we built a comprehensive model, taking all positive and
negative data points into account. In this case-study, we integrated the final classification-
model into our system. We used Pulmonary Fibrosis as testing disease. We applied the
disease to our system and generated a file with 200 predicted gene-candidates. These
genes are sorted by the number of publications that contain evidence for the disease-gene
association. The file was then evaluated by biomedical experts. In the following, we
describe the analysis of the generated file.
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Pre-evaluation Results of the Pulmonary Fibrosis-Classification Task In a pre-evaluation
of the predicted gene-candidates, each of the 200 genes is classified with one of the fol-
lowing labels:
• True Positive: Hit was found via co-occurrence.There is a clear connection to Pul-
monary Fibrosis.
• Pathway Candidate: Hints were found, that the gene is associated with Pulmonary
Fibrosis through relevant mechanism or pathways.
• Unclear/False Co-occurrence: Hit was found via co-occurrence, but the evidence for
a connection to Pulmonary Fibrosis is unclear or negative.
• False Positive: False positive in gene recognition.
• Potential Candidate: Needs to be investigated by fibrosis experts. Unfortunately, we
do not yet have any evaluation results, regarding to the potential gene-candidates.
The results of the pre-classification is shown in Table 6.8.
True Positive Pathway Candidate
Unclear/False
Co-occurrence
False Positive Potential Candidate
Count 54 12 26 19 89
Table 6.8: Results of the pre-labeling evaluation for 200 gene-candidates.
True Positive The pre-labeling evaluation shows that we were able to extract 54 true
positive genes. These genes are already known and can be extracted from the literature
through document-based co-occurrence. A further exploration of the true positives shows
that a lot of those genes are also related to cancer-diseases. This is probably caused by
two facts:
1. Pulmonary Fibrosis and Cancer are both tissue proliferation-diseases. Thus, they
share some basis symptoms, which may explain the overlap of genes.
2. Cancer-diseases are one of the most extensive studied disorders. This results in a
very large proportion of publication that are related to cancer. The high amount
of cancer related genes is may be attributable to a publication-bias towards cancer-
diseases.
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However, the predicted gene-candidates, which are also related to cancer, can be seen as
sensible hypothesis. Their actual relations to Pulmonary Fibrosis need further laboratory
experiments or experimental gene-expression data to prove that the genes are expressed
in the lung.
Pathway Candidate On top of that, we were able to find 12 genes that were related to
Pulmonary Fibrosis through gene-pathways. For example, we predicted the gene CDC42,
which is related to the gene PI3K, using a direct literature-evidence.
Unclear/False Co-occurrence 26 predicted genes are labeled as Unclear/False Co-
occurrence. One reason to assign this label, was if the provided evidence is based on
old publications. In few cases, the considered document contains a negative relation of a
gene to Pulmonary Fibrosis e.g. the publication with the PubMed ID 22273745:
”
Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but
not fibrosis.“
In the current system, we make use of a simple document based co-occurrence approach
to perform a pre-selection of gene candidates. This method includes no semantical or
contextual information at all, which leads to such false positives. However, those false
positives are very rare and their elimination demands a benefit-cost analysis in the first
place. A third reason to label a gene-candidate with Unclear/False Co-occurrence, is
a unclear relation to the disease. This could happen, if the gene-candidate is related
to a positive gene among longer or unknown pathways. To distinguish between false
positives that may have arise from wrong gene-normalization) and complex-true positives,
it requires a deeper investigation of the pathway.
False Positive 19 out of 200 are labeled with False Positive. Those genes are either
a product of a false gene recognition/normalization or belong to a viral-protein. To
identify such viral-proteins, it requires deeply contextual information. This information
can be extracted from the publication, in which the genes were described as disease-
related (directly through co-occurrence or indirectly through gene-pathways). However,
the disambiguation of proteins and viral-proteins goes beyond the scope of this thesis.
Potential Candidate All genes that need further investigations to determine, if they are
related to Pulmonary Fibrosis or not, are labeled with Potential Candidate. Our system
aims at the prediction of those potential gene-candidates and we were able to extract
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89. As mentioned before, the evaluation of these genes is very time consuming and
requires biomedical experts for fibrosis-diseases. As yet, we cannot draw any conclusions
concerning the accuracy of these candidates.
Summary From the pre-evaluation of the case-study, we summarize key-points:
1. We applied Pulmonary Fibrosis to our System and generate a file that contains 200
predictions of related genes.
2. In this case-study, the Best150 -classification model was used. It was previously
described in Section 6.1.2.
3. The aim of the system in combination with this model lays on the generation of
novel genes, that can be related to Pulmonary Fibrosis.
4. The genes within the generated files are ranked by their number of involved publi-
cations.
5. Our system produced 54 true positives, 19 false negatives, 12 likely-related genes,
26 unlikely-related genes and 89 other gene candidates.
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In this chapter, we conclude our work. We discuss briefly the systems architecture and
point out some advantages and issues that we left for future work. With a higher accuracy,
we discuss the evaluation results with respect to the used methods. Here too, we share
our ideas for future work in order to improve the systems performance.
The main objective of this thesis was to develop an approach that extracts and ranks novel
disease-related genes by their importance. Our work was motivated by the fact, that
current systems, which generate such novel gene-candidates, often lack in their ability
to deal with the huge amount of produced candidates. In order to achieve this goal,
we built a comprehensive disease-gene association extraction system. The approach, we
presented in this thesis, tackles the problem of association extraction by aggregating
information across millions of scientific publications and uses machine learning methods
to learn their importance to a given disease. Thereto, we extended the feature space of
common entity-relation features, like disease-gene co-occurrences, by novel features based
on a comprehensive gene-interaction network. This network was also utilized to predict
novel gene candidates.
A great challenge was to design a comprehensive system that can deal with the large
amount of data of publications and extracted information. Besides the very time con-
suming information extraction of diseases, genes and gene-events, we had to store all
information persistently. We reduced oﬄine and online processing time and focused our
results to human genes by limiting the taxonomic scope. Further, the design also in-
cludes the integration of existing state-of-the-art systems and self developed methods.
It implement their interactions properly and puts them into a running and functional
pipeline.
In the following, we discuss some key-designs and present ideas for future work. Our
system consists of several independent approaches for information extraction. We inte-
grated a CRF tagger by Klinger et al. [36] that tackles the disease-recognition. After
an extensive investigation of the recognized disease-mentions, we realized the need of
a disease-normalization. We tried to integrate the current state-of-the art framework
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DNorm. Using an existing framework, which is described in the literature can be a chal-
lenging task. A proper integration into a running pipeline often requires adaptations of
the source code and/or a communication with the developer. Both are very time con-
suming and the outcome is often unpredictable. Due to time issues, we discontinued our
efforts and implemented a simple disease normalization framework, called DiNo. DiNo’s
method was motivated by DNorm and with a strict adaptation to the output of the CRF
tagger, we achieved an F-Score of 61.49% on the BioCreativeII disease normalization task.
Unfortunately, we could not range on the same level as DNorm and there is a lot of room
for improvements. In the future, we could either continue our work of integrating DNorm
or improve DiNo.
Our combination of TEES and GeNo shows, that the combination of two well performing
systems does not necessarily result in an equally performing comprehensive system. We
integrated TEES for gene-event recognition, which aims at the extraction of gene-events
but does not distinguish between genes of various species. We restricted our system
to human genes and integrated the highly performing framework GeNo for the task of
gene normalization and disambiguation of the taxonomic scopes. Although, GeNo has
an integrated gene recognition module, thus we had to change its pipeline by integrating
TEES, since we were mainly interested in event-involved genes. Both facts, TEES’ non-
limitation to human genes and intersecting GeNo’s pipeline, effects the evaluation of the
gene normalization negatively. We achieved an F-Score of 55.33% on the BioCreativeII
gene normalization task. However, to the best of our knowledge, there is no existing
approach that tackles the event extraction with respect to human genes solely. To improve
the gene normalization, a future task could be integrating GeNo as gene recognition
framework into TEES, instead of the other way around.
In this work, we presented a method to reduce the complexity of gene-events. This
method includes several graph transformations, event simplifications and event-type gen-
eralizations. In agreement with biomedical experts, we developed a reduced GENIA
event scheme, which describes the new modified events. These modifications were moti-
vated in order to increase the gene-interaction density and to reduce the dimensionality
of the feature space. Up to this point, we did not investigate the impact of such gen-
eralizations, neither run any experiments to ensure their quality. An evaluation of the
event-modifications would go beyond the scope of this thesis and is left for future work.
In the following, we discuss the evaluation results of our final experiments. In order to
evaluate our system, several experiments were performed that can be divided into three
groups. In the first bunch of experiments, we evaluate some classification models. These
models were trained with a support vector machine in order to classify a gene as disease-
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related or not. Our dataset was composed of positive examples that could be gained
from the Genetic Testing Registry and negative examples from our database. Each data
point consisted exactly of one disease, one gene and a label (1 for a positive example,
respectively −1 for a negative example). A comprehensive feature vector was created
for each data point. To determine the best features, the Information Gain-method was
used. Our evaluations on the test set comprised several combinations of different features,
such as a limitation to the best n, only co-occurrence-based, only signature-based, etc. It
turned out, that using the co-occurrence based features led to the highest performance
(F-Score of 85.0%). The addition of the Gene Connectivity-features led to a drop in
F-Score of 0.7 points.
We recognized an interesting behavior by investigating the signature-based models on
the training set. By increasing the number of features (signatures), we recognized an
increasing precision by simultaneously decreasing recall and an almost constant F-Score of
66.5%. In combination with co-occurrence features, an opposite effect could be recognized.
Increasing the number of signature-features led to a drop in the precision but slightly
increase the recall. However, it seemed that this behavior converged at a number between
150-200 features. On the test set, the best model reached an F-Score of 82.3%.
We compared all results with the performance of our baseline-model which reached a
performance of 70.4% (F-Score) on the test set. A comparison of the results showed that,
considering the Path Signature-features only, could not outperform the baseline. However,
each hybrid-model outperformed the baseline on the training set by at least 9.8 points in
F-Score.
We decided to not choose the best performing model (Co+Connectivity) for the case-
study, but to use the best performing model that includes also signature-features. This
was mostly motivated by the following reasons:
1. The positive training examples from the gold-standard are human curated results of
experiments. We thereby assume that most of them were already published, which
lays a bias towards co-occurrence-based features.
2. One research question of our work was to determine, if signatures contain relevant
information to increase the performance of gene classification and gene ranking.
In a second evaluation, we have done several experiments to examine the performance
of the ranking task. Therefore, we trained support vector regression models with sim-
ilar setups to the classification experiments. Positive data points were extracted from
the DisGeNET -database, which provides a confidence score for each disease-gene asso-
ciation. Likewise to the classification data, we added negative training examples from
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our database. Instead of determining the Information Gain, which can not be used on
numeric class labels, we used a Subset Evaluation-technique to extract the best feature
subset. We compared the best feature-subset model with our baseline model, which got
a correlation coefficient (CC) of 0.436 and a Mean Absolute Error (MAE) of 0.134. The
comparison showed a slight improvement in MAE of 0.01 and a CC of 0.580. However,
the best performing model was a hybrid model that uses co-occurrence based features
in combination with gene-connectivity features. It outperforms the baseline in CC with
0.583 and a MAE of 0.116. We then evaluated all three models by integrating them into
the system and measure the Mean Reciprocal Rank (MRR) of the test set. It turned out,
that the best model performs at best with a MRR of 0.7067.
In a last evaluation, we conducted a case-study. We applied Pulmonary Fibrosis to
our system and generated a file that contains 200 predicted gene candidates, using a
classification model. In a pre-evaluation, these genes were labeled as true positive, false
positive, unlikely related, likely related or potential candidate. We were able to show that
our system successfully generates way more true positives and potential candidates than
false positives. However, due to the strict timeframe of this thesis, up to this point, we
do not have any evaluation results of the potential candidates.
In this thesis, we built a comprehensive system for the task of disease-gene-association
extraction across millions of biomedical publications. The aim of this thesis was to inte-
grate a machine learning based approach that uses novel features to learn the importance
of genes to a specific disease. Although we recognized that co-occurrence based feature
lead to a higher performance, we could show that using the novel features can be used to
predict novel gene-candidates. The current system can be seen as an essential foundation
that can be further optimized, extended or adapted to similar tasks.
92
Bibliography
[1] U.S. NLM PubMed. http://www.ncbi.nlm.nih.gov/pubmed. Accessed: 2015-04-
25.
[2] Hisham Al-Mubaid and Rajit K Singh. A new text mining approach for finding
protein-to-disease associations. American Journal of Biochemistry and Biotechnol-
ogy, 1(3):145, 2005.
[3] Rie Kubota Ando. Biocreative ii gene mention tagging system at ibm watson. In Pro-
ceedings of the Second BioCreative Challenge Evaluation Workshop, volume 23, pages
101–103. Centro Nacional de Investigaciones Oncologicas (CNIO) Madrid, Spain,
2007.
[4] Cecilia N Arighi, Zhiyong Lu, Martin Krallinger, Kevin B Cohen, W John Wilbur,
Alfonso Valencia, Lynette Hirschman, and Cathy H Wu. Overview of the biocreative
iii workshop. BMC bioinformatics, 12(Suppl 8):S1, 2011.
[5] Ken Arnold, James Gosling, David Holmes, and David Holmes. The Java program-
ming language, volume 2. Addison-wesley Reading, 1996.
[6] R Baud et al. Improving literature based discovery support by genetic knowledge
integration. The New Navagators: From Professionals to Patients, 95:68, 2003.
[7] Jari Bjo¨rne, Antti Airola, Tapio Pahikkala, and Tapio Salakoski. Drug-drug inter-
action extraction from biomedical texts with svm and rls classifiers. Proceedings of
DDIExtraction-2011 challenge task, pages 35–42, 2011.
[8] Jari Bjo¨rne, Filip Ginter, Sampo Pyysalo, Jun’ichi Tsujii, and Tapio Salakoski. Com-
plex event extraction at pubmed scale. Bioinformatics, 26(12):i382–i390, 2010.
[9] Jari Bjo¨rne, Juho Heimonen, Filip Ginter, Antti Airola, Tapio Pahikkala, and Tapio
Salakoski. Extracting complex biological events with rich graph-based feature sets.
In Proceedings of the Workshop on Current Trends in Biomedical Natural Language
Processing: Shared Task, pages 10–18. Association for Computational Linguistics,
2009.
93
Bibliography
[10] Jari Bjo¨rne and Tapio Salakoski. Generalizing biomedical event extraction. In Pro-
ceedings of the BioNLP Shared Task 2011 Workshop, pages 183–191. Association for
Computational Linguistics, 2011.
[11] Jari Bjo¨rne, Sofie Van Landeghem, Sampo Pyysalo, Tomoko Ohta, Filip Ginter, Yves
Van de Peer, Sophia Ananiadou, and Tapio Salakoski. Pubmed-scale event extraction
for post-translational modifications, epigenetics and protein structural relations. In
Proceedings of the 2012 Workshop on Biomedical Natural Language Processing, pages
82–90. Association for Computational Linguistics, 2012.
[12] Olivier Bodenreider. The unified medical language system (umls): integrating
biomedical terminology. Nucleic acids research, 32(suppl 1):D267–D270, 2004.
[13] Dan Brickley and Ramanathan V Guha. Resource description framework (rdf)
schema specification 1.0: W3c candidate recommendation 27 march 2000. 2000.
[14] Jeen Broekstra, Arjohn Kampman, and Frank Van Harmelen. Sesame: A generic ar-
chitecture for storing and querying rdf and rdf schema. In The Semantic Web—ISWC
2002, pages 54–68. Springer, 2002.
[15] Chih-Chung Chang and Chih-Jen Lin. Libsvm: a library for support vector machines.
ACM Transactions on Intelligent Systems and Technology (TIST), 2(3):27, 2011.
[16] Danqi Chen and Christopher D Manning. A fast and accurate dependency parser
using neural networks. In Proceedings of the 2014 Conference on Empirical Methods
in Natural Language Processing (EMNLP), pages 740–750, 2014.
[17] Hong-Woo Chun, Yoshimasa Tsuruoka, Jin-Dong Kim, Rie Shiba, Naoki Nagata,
Teruyoshi Hishiki, and Jun’ichi Tsujii. Extraction of gene-disease relations from
medline using domain dictionaries and machine learning. In Pacific Symposium on
Biocomputing, volume 11, pages 4–15, 2006.
[18] UniProt Consortium et al. Update on activities at the universal protein resource
(uniprot) in 2013. Nucleic acids research, 41(D1):D43–D47, 2013.
[19] Corinna Cortes and Vladimir Vapnik. Support-vector networks. Machine learning,
20(3):273–297, 1995.
[20] Nick Craswell. Mean reciprocal rank. In Encyclopedia of Database Systems, pages
1703–1703. Springer, 2009.
[21] James A Cuff and Geoffrey J Barton. Application of multiple sequence alignment
profiles to improve protein secondary structure prediction. Proteins: Structure, Func-
tion, and Bioinformatics, 40(3):502–511, 2000.
94
Bibliography
[22] Allan Peter Davis, Cynthia Grondin Murphy, Robin Johnson, Jean M Lay, Kel-
ley Lennon-Hopkins, Cynthia Saraceni-Richards, Daniela Sciaky, Benjamin L King,
Michael C Rosenstein, Thomas C Wiegers, et al. The comparative toxicogenomics
database: update 2013. Nucleic acids research, page gks994, 2012.
[23] Rezarta Islamaj Dog˘an, Robert Leaman, and Zhiyong Lu. Ncbi disease corpus: a re-
source for disease name recognition and concept normalization. Journal of biomedical
informatics, 47:1–10, 2014.
[24] Andreas Doms and Michael Schroeder. Gopubmed: exploring pubmed with the gene
ontology. Nucleic acids research, 33(suppl 2):W783–W786, 2005.
[25] Haw-ren Fang, Kevin Murphy, Yang Jin, Jessica S. Kim, and Peter S. White. Human
gene name normalization using text matching with automatically extracted synonym
dictionaries. In Proceedings of the Workshop on Linking Natural Language Processing
and Biology: Towards Deeper Biological Literature Analysis, BioNLP ’06, pages 41–
48, Stroudsburg, PA, USA, 2006. Association for Computational Linguistics.
[26] Katrin Fundel, Robert Ku¨ffner, and Ralf Zimmer. Relex—relation extraction using
dependency parse trees. Bioinformatics, 23(3):365–371, 2007.
[27] Claudio Giuliano, Alberto Lavelli, and Lorenza Romano. Exploiting shallow linguistic
information for relation extraction from biomedical literature. In EACL, volume 18,
pages 401–408. Citeseer, 2006.
[28] Jo¨rg Hakenberg, Conrad Plake, Robert Leaman, Michael Schroeder, and Graciela
Gonzalez. Inter-species normalization of gene mentions with gnat. Bioinformatics,
24(16):i126–i132, 2008.
[29] Mark Hall, Eibe Frank, Geoffrey Holmes, Bernhard Pfahringer, Peter Reutemann,
and Ian H Witten. The weka data mining software: an update. ACM SIGKDD
explorations newsletter, 11(1):10–18, 2009.
[30] Mark A Hall. Correlation-based feature selection for machine learning. PhD thesis,
The University of Waikato, 1999.
[31] Ada Hamosh, Alan F Scott, Joanna S Amberger, Carol A Bocchini, and Victor A
McKusick. Online mendelian inheritance in man (omim), a knowledgebase of human
genes and genetic disorders. Nucleic acids research, 33(suppl 1):D514–D517, 2005.
[32] Dimitar Hristovski, Thomas Rindflesch, and Borut Peterlin. Using literature-
based discovery to identify novel therapeutic approaches. Cardiovascular & Hema-
tological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-
95
Bibliography
Cardiovascular & Hematological Agents), 11(1):14–24, 2013.
[33] Jin-Dong Kim, Tomoko Ohta, Sampo Pyysalo, Yoshinobu Kano, and Jun’ichi Tsujii.
Overview of bionlp’09 shared task on event extraction. In Proceedings of the Work-
shop on Current Trends in Biomedical Natural Language Processing: Shared Task,
pages 1–9. Association for Computational Linguistics, 2009.
[34] Jin-Dong Kim, Tomoko Ohta, and Jun’ichi Tsujii. Corpus annotation for mining
biomedical events from literature. BMC bioinformatics, 9(1):10, 2008.
[35] Jin-Dong Kim, Sampo Pyysalo, Tomoko Ohta, Robert Bossy, Ngan Nguyen, and
Jun’ichi Tsujii. Overview of bionlp shared task 2011. In Proceedings of the BioNLP
Shared Task 2011 Workshop, pages 1–6. Association for Computational Linguistics,
2011.
[36] Roman Klinger, Christoph M Friedrich, Juliane Fluck, and Martin Hofmann-Apitius.
Named entity recognition with combinations of conditional random fields. In Pro-
ceedings of the second biocreative challenge evaluation workshop, 2007.
[37] Solomon Kullback and Richard A Leibler. On information and sufficiency. The annals
of mathematical statistics, pages 79–86, 1951.
[38] Robert Leaman, Rezarta Islamaj Dog˘an, and Zhiyong Lu. Dnorm: disease name
normalization with pairwise learning to rank. Bioinformatics, page btt474, 2013.
[39] Robert Leaman, Graciela Gonzalez, et al. Banner: an executable survey of advances
in biomedical named entity recognition. In Pacific Symposium on Biocomputing,
volume 13, pages 652–663. Citeseer, 2008.
[40] Robert Leaman, Christopher Miller, and G Gonzalez. Enabling recognition of diseases
in biomedical text with machine learning: corpus and benchmark. In Proceedings of
the 2009 Symposium on Languages in Biology and Medicine, volume 82, 2009.
[41] Joseph Lee Rodgers and W Alan Nicewander. Thirteen ways to look at the correlation
coefficient. The American Statistician, 42(1):59–66, 1988.
[42] Vladimir I Levenshtein. Binary codes capable of correcting deletions, insertions, and
reversals. In Soviet physics doklady, volume 10, pages 707–710, 1966.
[43] Dingcheng Li, Karin Kipper-Schuler, and Guergana Savova. Conditional random
fields and support vector machines for disorder named entity recognition in clinical
texts. In Proceedings of the Workshop on Current Trends in Biomedical Natural
Language Processing, BioNLP ’08, pages 94–95, Stroudsburg, PA, USA, 2008. Asso-
ciation for Computational Linguistics.
96
Bibliography
[44] Carolyn E Lipscomb. Medical subject headings (mesh). Bulletin of the Medical
Library Association, 88(3):265, 2000.
[45] Donna Maglott, Jim Ostell, Kim D Pruitt, and Tatiana Tatusova. Entrez gene: gene-
centered information at ncbi. Nucleic acids research, 39(suppl 1):D52–D57, 2011.
[46] Alexander A Morgan, Zhiyong Lu, Xinglong Wang, Aaron M Cohen, Juliane Fluck,
Patrick Ruch, Anna Divoli, Katrin Fundel, Robert Leaman, Jo¨rg Hakenberg, et al.
Overview of biocreative ii gene normalization. Genome biology, 9(Suppl 2):S3, 2008.
[47] Claire Ne´dellec, Robert Bossy, Jin-Dong Kim, Jung-Jae Kim, Tomoko Ohta, Sampo
Pyysalo, and Pierre Zweigenbaum. Overview of bionlp shared task 2013. In Proceed-
ings of the BioNLP Shared Task 2013 Workshop, pages 1–7, 2013.
[48] Tomoko Ohta, Yoshimasa Tsuruoka, Jumpei Takeuchi, Jin-Dong Kim, Yusuke Miyao,
Akane Yakushiji, Kazuhiro Yoshida, Yuka Tateisi, Takashi Ninomiya, Katsuya Ma-
suda, et al. An intelligent search engine and gui-based efficient medline search tool
based on deep syntactic parsing. In Proceedings of the COLING/ACL on Interactive
presentation sessions, pages 17–20. Association for Computational Linguistics, 2006.
[49] Arzucan O¨zgu¨r, Thuy Vu, Gu¨nes¸ Erkan, and Dragomir R Radev. Identifying gene-
disease associations using centrality on a literature mined gene-interaction network.
Bioinformatics, 24(13):i277–i285, 2008.
[50] Benjamin Paassen, Andreas Sto¨ckel, Raphael Dickfelder, Jan Philip Go¨pfert, Nicole
Brazda, Tarek Kirchhoffer, Hans Werner Mu¨ller, Roman Klinger, Matthias Hartung,
and Philipp Cimiano. Ontology-based extraction of structured information from
publications on preclinical experiments for spinal cord injury treatments. In Third
Workshop on Semantic Web and Information Extraction (SWAIE). The 25th Inter-
national Conference on Computational Linguistics (COLING), 2014.
[51] Janet Pin˜ero, Nu´ria Queralt-Rosinach, A`lex Bravo, Jordi Deu-Pons, Anna Bauer-
Mehren, Martin Baron, Ferran Sanz, and Laura I Furlong. Disgenet: a discovery
platform for the dynamical exploration of human diseases and their genes. Database,
2015:bav028, 2015.
[52] Sune Pletscher-Frankild, Albert Palleja`, Kalliopi Tsafou, Janos X Binder, and
Lars Juhl Jensen. Diseases: Text mining and data integration of disease–gene asso-
ciations. Methods, 2014.
[53] Changqin Quan and Fuji Ren. Gene–disease association extraction by text mining
and network analysis. In Proceedings of the 5th International Workshop on Health
Text Mining and Information Analysis (Louhi)@ EACL, pages 54–63, 2014.
97
Bibliography
[54] Wendy S Rubinstein, Donna R Maglott, Jennifer M Lee, Brandi L Kattman, Adri-
ana J Malheiro, Michael Ovetsky, Vichet Hem, Viatcheslav Gorelenkov, Guangfeng
Song, Craig Wallin, et al. The nih genetic testing registry: a new, centralized database
of genetic tests to enable access to comprehensive information and improve trans-
parency. Nucleic acids research, page gks1173, 2012.
[55] Rune Sætre, Kazuhiro Yoshida, Akane Yakushiji, Yusuke Miyao, Yuichiro Matsub-
ayashi, and Tomoko Ohta. Akane system: protein-protein interaction pairs in biocre-
ative2 challenge, ppi-ips subtask. In Proceedings of the Second BioCreative Challenge
Workshop, pages 209–212, 2007.
[56] Eric W Sayers, Tanya Barrett, Dennis A Benson, Evan Bolton, Stephen H Bryant,
Kathi Canese, Vyacheslav Chetvernin, Deanna M Church, Michael DiCuccio, Scott
Federhen, et al. Database resources of the national center for biotechnology informa-
tion. Nucleic acids research, 39(suppl 1):D38–D51, 2011.
[57] Claude Elwood Shannon. A mathematical theory of communication. ACM SIGMO-
BILE Mobile Computing and Communications Review, 5(1):3–55, 2001.
[58] John Shawe-Taylor and Nello Cristianini. Kernel methods for pattern analysis. Cam-
bridge university press, 2004.
[59] Mir S Siadaty, Jianfen Shu, and William A Knaus. Relemed: sentence-level search
engine with relevance score for the medline database of biomedical articles. BMC
medical informatics and decision making, 7(1):1, 2007.
[60] S Skiena. Dijkstra’s algorithm. Implementing Discrete Mathematics: Combinatorics
and Graph Theory with Mathematica, Reading, MA: Addison-Wesley, pages 225–227,
1990.
[61] Alex J Smola and Bernhard Scho¨lkopf. A tutorial on support vector regression.
Statistics and computing, 14(3):199–222, 2004.
[62] Pontus Stenetorp, Goran Topic´, Sampo Pyysalo, Tomoko Ohta, Jin-Dong Kim, and
Jun’ichi Tsujii. Bionlp shared task 2011: Supporting resources. In Proceedings of the
BioNLP Shared Task 2011 Workshop, pages 112–120. Association for Computational
Linguistics, 2011.
[63] Johan AK Suykens and Joos Vandewalle. Least squares support vector machine
classifiers. Neural processing letters, 9(3):293–300, 1999.
[64] Don R Swanson. Fish oil, raynaud’s syndrome, and undiscovered public knowledge.
Perspectives in biology and medicine, 30(1):7–18, 1986.
98
Bibliography
[65] Don R Swanson and Neil R Smalheiser. Undiscovered public knowledge: A ten-year
update. In KDD, pages 295–298, 1996.
[66] Tzong-Han Tsai, Shih-Hung Wu, and Wen-Lian Hsu. Exploitation of linguistic fea-
tures using a crf-based biomedical named entity recognizer. In Proceedings of Bi-
oLINK, volume 2005, 2005.
[67] Yoshimasa Tsuruoka, John McNaught, and Sophia Ananiadou. Normalizing biomed-
ical terms by minimizing ambiguity and variability. BMC bioinformatics, 9(Suppl
3):S2, 2008.
[68] Marc A van Driel, Koen Cuelenaere, Patrick PCW Kemmeren, Jack AM Leunissen,
and Han G Brunner. A new web-based data mining tool for the identification of
candidate genes for human genetic disorders. European Journal of Human Genetics,
11(1):57–63, 2003.
[69] Sofie Van Landeghem, Jari Bjo¨rne, Chih-Hsuan Wei, Kai Hakala, Sampo Pyysalo,
Sophia Ananiadou, Hung-Yu Kao, Zhiyong Lu, Tapio Salakoski, Yves Van de Peer,
et al. Large-scale event extraction from literature with multi-level gene normalization.
PloS one, 8(4):e55814, 2013.
[70] Ellen M Voorhees et al. The trec-8 question answering track report. In TREC,
volume 99, pages 77–82, 1999.
[71] Chih-Hsuan Wei and Hung-Yu Kao. Cross-species gene normalization by species
inference. BMC bioinformatics, 12(Suppl 8):S5, 2011.
[72] Joachim Wermter, Katrin Tomanek, and Udo Hahn. High-performance gene name
normalization with geno. Bioinformatics, 25(6):815–821, 2009.
[73] Jonathan D Wren, Raffi Bekeredjian, Jelena A Stewart, Ralph V Shohet, and
Harold R Garner. Knowledge discovery by automated identification and ranking
of implicit relationships. Bioinformatics, 20(3):389–398, 2004.
99

Eigensta¨ndigkeitserkla¨rung
Master’s Thesis: Declaration of Authorship - Hendrik ter Horst
Hiermit erkla¨re ich, dass ich die vorliegende Masterarbeit selbsta¨ndig verfasst und gelieferte
Datensa¨tze, Zeichnungen, Skizzen und graphische Darstellungen selbsta¨ndig erstellt habe.
Ich habe keine anderen Quellen als die angegebenen benutzt und habe die Stellen der
Arbeit, die anderen Werken entnommen sind - einschl. verwendeter Tabellen und Ab-
bildungen - in jedem einzelnen Fall unter Angabe der Quelle als Entlehnung kenntlich
gemacht.
Bielefeld, Mai 2015 Hendrik ter Horst
101
